SIMPLIFIER.NET - FHIRPath Playground

FHIRPath

If you Log in or sign up, you can edit this script yourself.

name

{
  "resourceType": "CodeSystem",
  "id": "849bc27b-a66d-49ad-9389-d8f19d63b480",
  "meta": {
    "versionId": "1",
    "lastUpdated": "2025-08-11T08:51:38.179+00:00"
  },
  "url": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
  "identifier": [
    {
      "system": "http://legemiddelverket.no/fhir/SAFEST/SafestCodeSystemID",
      "value": "849bc27b-a66d-49ad-9389-d8f19d63b480"
    },
    {
      "system": "http://legemiddelverket.no/fhir/SAFEST/ListID",
      "value": "100000096613"
    }
  ],
  "name": "Anatomical Therapeutic Chemical classification system - Human - Antineoplastic and immunomodulating agents Examples",
  "status": "active",
  "content": "complete",
  "property": [
    {
      "code": "parentATC",
      "description": "Parent ATC",
      "type": "Coding"
    },
    {
      "code": "fromDate",
      "description": "From Date",
      "type": "Coding"
    },
    {
      "code": "toDate",
      "description": "To Date",
      "type": "Coding"
    },
    {
      "code": "previousVersion",
      "description": "Previous Version",
      "type": "Coding"
    },
    {
      "code": "ATCCode",
      "description": "ATC Code",
      "type": "Coding"
    },
    {
      "code": "internalCode",
      "description": "Internal code",
      "type": "Coding"
    },
    {
      "code": "termIdRms",
      "description": "RMS ID",
      "type": "Coding"
    },
    {
      "code": "internalTermStatus",
      "description": "Status (internal)",
      "type": "Coding"
    },
    {
      "code": "sourceTermStatus",
      "description": "Status (RMS)",
      "type": "Coding"
    }
  ],
  "concept": [
    {
      "code": "L04AK",
      "display": "Dihydroorotate dehydrogenase (DHODH) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dihydroorotate dehydrogenase (DHODH) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dihydroorotatdehydrogenase (DHODH) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AK",
            "display": "L04AK"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AK"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CA",
      "display": "Vinca alkaloids and analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vinca alkaloids and analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vinkaalkaloider og analoger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA",
            "display": "L01CA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX62",
      "display": "Ivosidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ivosidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ivosidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX62",
            "display": "L01XX62"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2025-01-15T00:00:00Z",
            "display": "2025-01-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX62"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XF03",
      "display": "Bexarotene",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bexarotene"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Beksaroten"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XF",
            "display": "Retinoids for cancer treatment"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX25",
            "display": "Bexarotene"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XF03",
            "display": "L01XF03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XF03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AB02",
      "display": "Treosulfan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Treosulfan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Treosulfan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AB",
            "display": "Alkyl sulfonates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AB02",
            "display": "L01AB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CA01",
      "display": "Vinblastine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vinblastine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vinblastin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA01",
            "display": "L01CA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CB",
      "display": "Podophyllotoxin derivatives",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Podophyllotoxin derivatives"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Podofyllotoksinderivater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CB",
            "display": "L01CB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH06",
      "display": "Tucidinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tucidinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tucidinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH06",
            "display": "L01XH06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE19",
      "display": "Ridaforolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ridaforolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ridaforolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE19",
            "display": "L01XE19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-01-28T00:00:00Z",
            "display": "2013-01-28T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AA02",
      "display": "Chlorambucil",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Chlorambucil"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Klorambucil"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA02",
            "display": "L01AA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG",
      "display": "Aromatase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aromatase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aromatasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02B",
            "display": "Hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG",
            "display": "L02BG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA09",
      "display": "Sargramostim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sargramostim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sargramostim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA09",
            "display": "L03AA09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FA",
      "display": "CD20 (Clusters of differentitation 20) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "CD20 (Clusters of differentitation 20) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "CD20 (Differensieringsantigen 20) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FA",
            "display": "L01FA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX04",
      "display": "Ipilimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ipilimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ipilimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC11",
            "display": "Ipilimumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX04",
            "display": "L01FX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA46",
      "display": "Itacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Itacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Itakitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA46",
            "display": "L04AA46"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA46"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FB",
      "display": "CD22 (Clusters of differentitation 22) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "CD22 (Clusters of differentitation 22) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "CD22 (Differensieringsantigen 22) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FB",
            "display": "L01FB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EG04",
      "display": "Sirolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EG",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EG04",
            "display": "L01EG04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EG04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB60",
      "display": "Peginterferon-alfa-2b, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon-alfa-2b, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2b, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB60",
            "display": "L03AB60"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB60"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA38",
      "display": "Ozanimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ozanimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ozanimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA38",
            "display": "L04AA38"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA38"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EM04",
      "display": "Duvelisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Duvelisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Duvelisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EM",
            "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM04",
            "display": "L01EM04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XF",
      "display": "Retinoids for cancer treatment",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Retinoids for cancer treatment"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Retinoider for kreftbehandling"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XF",
            "display": "L01XF"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XF"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FG02",
      "display": "Ramucirumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ramucirumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ramucirumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FG",
            "display": "VEGF/VEGFR (Vascular endothelial growth factor) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC21",
            "display": "Ramucirumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FG02",
            "display": "L01FG02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FG02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EK03",
      "display": "Tivozanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tivozanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tivozanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EK",
            "display": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE34",
            "display": "Tivozanib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EK03",
            "display": "L01EK03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EK03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX22",
      "display": "Leniolisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Leniolisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Leniolisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX22",
            "display": "L03AX22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE52",
      "display": "Quizartinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Quizartinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kizartinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE52",
            "display": "L01XE52"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE52"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XH04",
      "display": "Belinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX49",
            "display": "Belinostat"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH04",
            "display": "L01XH04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX",
      "display": "Other antineoplastic agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other antineoplastic agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre antineoplastiske midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX",
            "display": "L01XX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX54",
      "display": "Niraparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX54",
            "display": "L01XX54"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-11T00:00:00Z",
            "display": "2017-01-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX54"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02AA04",
      "display": "Fosfestrol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fosfestrol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fosfestrol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AA",
            "display": "Estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AA04",
            "display": "L02AA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EN03",
      "display": "Infigratinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Infigratinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Infigratinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EN",
            "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EN03",
            "display": "L01EN03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EN03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE04",
      "display": "Sunitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sunitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sunitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE04",
            "display": "L01XE04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-01-01T00:00:00Z",
            "display": "2007-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX36",
      "display": "Oblimersen",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Oblimersen"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Oblimersen"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX36",
            "display": "L01XX36"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX36"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FG",
      "display": "VEGF/VEGFR (Vascular endothelial growth factor) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "VEGF/VEGFR (Vascular endothelial growth factor) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "VEGF/VEGFR (Vaskulær endotel vekstfaktor) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FG",
            "display": "L01FG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE38",
      "display": "Cobimetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cobimetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kobimetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE38",
            "display": "L01XE38"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE38"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XD",
      "display": "Sensitizers used in photodynamic/radiation therapy",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sensitizers used in photodynamic/radiation therapy"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aktiverende midler til fotodynamisk- og stråleterapi"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD",
            "display": "L01XD"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX42",
      "display": "Panobinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Panobinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Panobinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX42",
            "display": "L01XX42"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX42"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AG04",
      "display": "Belimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA26",
            "display": "Belimumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG04",
            "display": "L04AG04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC14",
      "display": "Sarilumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sarilumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sarilumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC14",
            "display": "L04AC14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-06-28T00:00:00Z",
            "display": "2016-06-28T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX14",
      "display": "Histamine dihydrochloride",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Histamine dihydrochloride"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Histamindihydroklorid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX14",
            "display": "L03AX14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-11-21T00:00:00Z",
            "display": "2006-11-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BX01",
      "display": "Abarelix",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abarelix"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abareliks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BX",
            "display": "Other hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX01",
            "display": "L02BX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX14",
      "display": "Polatuzumab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Polatuzumab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Polatuzumabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC37",
            "display": "Polatuzumab vedotin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX14",
            "display": "L01FX14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AE02",
      "display": "Ozanimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ozanimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ozanimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AE",
            "display": "Sphingosine-1-phosphate (S1P) receptor modulators"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA38",
            "display": "Ozanimod"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE02",
            "display": "L04AE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AC02",
      "display": "Triaziquone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Triaziquone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Triazikon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AC",
            "display": "Ethylene imines"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AC02",
            "display": "L01AC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL12",
      "display": "Obecabtagene autoleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Obecabtagene autoleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Obekabtagenautoleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL12",
            "display": "L01XL12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF07",
      "display": "Deucravacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Deucravacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Deukravacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA56",
            "display": "Deucravacitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF07",
            "display": "L04AF07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-04-19T00:00:00Z",
            "display": "2023-04-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EC02",
      "display": "Dabrafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dabrafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dabrafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EC",
            "display": "B-Raf serine-threonine kinase (BRAF) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE23",
            "display": "Dabrafenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EC02",
            "display": "L01EC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX12",
      "display": "Tafasitamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tafasitamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tafasitamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC35",
            "display": "Tafasitamab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX12",
            "display": "L01FX12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB11",
      "display": "Pixantrone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pixantrone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Piksantron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB11",
            "display": "L01DB11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-11-29T00:00:00Z",
            "display": "2010-11-29T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AB",
      "display": "Alkyl sulfonates",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alkyl sulfonates"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alkylsulfonater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AB",
            "display": "L01AB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AE03",
      "display": "Siponimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Siponimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Siponimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AE",
            "display": "Sphingosine-1-phosphate (S1P) receptor modulators"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA42",
            "display": "Siponimod"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE03",
            "display": "L04AE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX67",
      "display": "Tagraxofusp",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tagraxofusp"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tagraksofusp"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX67",
            "display": "L01XX67"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX67"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX03",
      "display": "Methotrexate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Methotrexate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Metotreksat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX03",
            "display": "L04AX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-03-11T00:00:00Z",
            "display": "2004-03-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE13",
      "display": "Afatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Afatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Afatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE13",
            "display": "L01XE13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC31",
      "display": "Avelumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Avelumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Avelumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC31",
            "display": "L01XC31"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-11-01T00:00:00Z",
            "display": "2017-11-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC31"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EM02",
      "display": "Copanlisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Copanlisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kopanlisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EM",
            "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX61",
            "display": "Copanlisib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM02",
            "display": "L01EM02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA14",
      "display": "Lipegfilgrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lipegfilgrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lipegfilgrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA14",
            "display": "L03AA14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-01-29T00:00:00Z",
            "display": "2013-01-29T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AC02",
      "display": "Oprelvekin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Oprelvekin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Oprelvekin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AC",
            "display": "Interleukins"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AC02",
            "display": "L03AC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG02",
      "display": "Formestane",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Formestane"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Formestan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG02",
            "display": "L02BG02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC32",
      "display": "Atezolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Atezolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Atezolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC32",
            "display": "L01XC32"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-09-21T00:00:00Z",
            "display": "2017-09-21T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC32"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AF08",
      "display": "Ritlecitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ritlecitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ritlecitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF08",
            "display": "L04AF08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-08-04T00:00:00Z",
            "display": "2023-08-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA59",
      "display": "Avacopan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Avacopan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Avakopan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA59",
            "display": "L04AA59"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA59"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX64",
      "display": "Entinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Entinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Entinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX64",
            "display": "L01XX64"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX64"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE21",
      "display": "Regorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Regorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Regorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE21",
            "display": "L01XE21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-06-06T00:00:00Z",
            "display": "2012-06-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE26",
      "display": "Cabozantinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cabozantinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kabozantinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE26",
            "display": "L01XE26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-11-15T00:00:00Z",
            "display": "2013-11-15T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XL08",
      "display": "Lisocabtagene maraleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lisocabtagene maraleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lisokabtagenmaraleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL08",
            "display": "L01XL08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX",
      "display": "Other protein kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other protein kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre proteinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX",
            "display": "L01EX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG10",
      "display": "Inebilizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Inebilizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Inebilizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA47",
            "display": "Inebilizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG10",
            "display": "L04AG10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB07",
      "display": "Opinercept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Opinercept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Opinercept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB07",
            "display": "L04AB07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX03",
      "display": "BCG vaccine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "BCG vaccine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "BCG vaksine"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX03",
            "display": "L03AX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EE03",
      "display": "Binimetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Binimetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Binimetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EE",
            "display": "Mitogen-activated protein kinase (MEK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE41",
            "display": "Binimetinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE03",
            "display": "L01EE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA13",
      "display": "Leflunomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Leflunomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Leflunomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA13",
            "display": "L04AA13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EM05",
      "display": "Parsaclisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Parsaclisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Parsaklisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EM",
            "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM05",
            "display": "L01EM05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX08",
      "display": "Darvadstrocel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Darvadstrocel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Darvadstrocel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX08",
            "display": "L04AX08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA",
      "display": "Nitrogen mustard analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nitrogen mustard analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sennepsgassanaloger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA",
            "display": "L01AA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX05",
      "display": "Pirfenidone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pirfenidone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pirfenidon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX05",
            "display": "L04AX05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-03-17T00:00:00Z",
            "display": "2011-03-17T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA32",
      "display": "Apremilast",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Apremilast"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Apremilast"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA32",
            "display": "L04AA32"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA32"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BA05",
      "display": "Pralatrexate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pralatrexate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pralatreksat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BA",
            "display": "Folic acid analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BA05",
            "display": "L01BA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX05",
      "display": "Hydroxycarbamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Hydroxycarbamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Hydroksykarbamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX05",
            "display": "L01XX05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC38",
      "display": "Isatuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Isatuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Isatuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC38",
            "display": "L01XC38"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-06-22T00:00:00Z",
            "display": "2020-06-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC38"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX11",
      "display": "Quizartinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Quizartinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kvizartinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE52",
            "display": "Quizartinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX11",
            "display": "L01EX11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC40",
      "display": "Dostarlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dostarlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dostarlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC40",
            "display": "L01XC40"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC40"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX10",
      "display": "Masoprocol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Masoprocol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Masoprokol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX10",
            "display": "L01XX10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX01",
      "display": "Azathioprine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Azathioprine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Azatioprin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX01",
            "display": "L04AX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH03",
      "display": "Panobinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Panobinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Panobinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX42",
            "display": "Panobinostat"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH03",
            "display": "L01XH03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EF01",
      "display": "Palbociclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Palbociclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Palbociklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EF",
            "display": "Cyclin-dependent kinases (CDK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE33",
            "display": "Palbociclib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EF01",
            "display": "L01EF01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EF01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB03",
      "display": "Interferon gamma",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon gamma"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon gamma"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB03",
            "display": "L03AB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC12",
      "display": "Brentuximab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brentuximab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brentuksimabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC12",
            "display": "L01XC12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-06-30T00:00:00Z",
            "display": "2011-06-30T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AE01",
      "display": "Fingolimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fingolimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fingolimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AE",
            "display": "Sphingosine-1-phosphate (S1P) receptor modulators"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA27",
            "display": "Fingolimod"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE01",
            "display": "L04AE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA03",
      "display": "Nilotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nilotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nilotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE08",
            "display": "Nilotinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA03",
            "display": "L01EA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AG01",
      "display": "Etoglucid",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etoglucid"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etoglucid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AG",
            "display": "Epoxides"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AG01",
            "display": "L01AG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DA",
      "display": "Actinomycines",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Actinomycines"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aktinomyciner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01D",
            "display": "Cytotoxic antibiotics and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DA",
            "display": "L01DA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02A",
      "display": "Hormones and related agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Hormones and related agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Hormoner og beslektede substanser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02",
            "display": "Endocrine therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02A",
            "display": "L02A"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02A"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX06",
      "display": "Masitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Masitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Masitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE22",
            "display": "Masitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX06",
            "display": "L01EX06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC08",
      "display": "Canakinumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Canakinumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kanakinumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC08",
            "display": "L04AC08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XU",
      "display": "Other antineoplastic agents (cont.)",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other antineoplastic agents (cont.)"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre antineoplastiske midler (forts.)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XU",
            "display": "L01XU"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-12-08T00:00:00Z",
            "display": "2024-12-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XU"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD03",
      "display": "Trastuzumab emtansine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab emtansine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumabemtansin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC14",
            "display": "Trastuzumab emtansine"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD03",
            "display": "L01FD03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE43",
      "display": "Brigatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brigatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brigatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE43",
            "display": "L01XE43"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-10T00:00:00Z",
            "display": "2017-01-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE43"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX25",
      "display": "Bexarotene",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bexarotene"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Beksaroten"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX25",
            "display": "L01XX25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XK02",
      "display": "Niraparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX54",
            "display": "Niraparib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK02",
            "display": "L01XK02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AC",
      "display": "Ethylene imines",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ethylene imines"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etyleniminer"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AC",
            "display": "L01AC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC58",
      "display": "Decitabine, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Decitabine, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Decitabin, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC58",
            "display": "L01BC58"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-22T00:00:00Z",
            "display": "2023-11-22T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC58"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC21",
      "display": "Ramucirumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ramucirumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ramucirumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC21",
            "display": "L01XC21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-02-17T00:00:00Z",
            "display": "2015-02-17T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EG03",
      "display": "Ridaforolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ridaforolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ridaforolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EG",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE19",
            "display": "Ridaforolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EG03",
            "display": "L01EG03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EG03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX27",
      "display": "Arsenic trioxide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Arsenic trioxide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Arsentrioksid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX27",
            "display": "L01XX27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AB01",
      "display": "Megestrol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Megestrol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Megestrol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AB",
            "display": "Progestogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AB01",
            "display": "L02AB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX21",
      "display": "Naxitamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Naxitamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Naksitamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX21",
            "display": "L01FX21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE24",
      "display": "Ponatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ponatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ponatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE24",
            "display": "L01XE24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-09-02T00:00:00Z",
            "display": "2013-09-02T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XL03",
      "display": "Axicabtagene ciloleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Axicabtagene ciloleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aksikabtagenciloleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX70",
            "display": "Axicabtagene ciloleucel"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL03",
            "display": "L01XL03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-09-09T00:00:00Z",
            "display": "2022-09-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED02",
      "display": "Ceritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ceritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ceritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01ED",
            "display": "Anaplastic lymphoma kinase (ALK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE28",
            "display": "Ceritinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED02",
            "display": "L01ED02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX66",
      "display": "Selinexor",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Selinexor"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Selineksor"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX66",
            "display": "L01XX66"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX66"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE41",
      "display": "Binimetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Binimetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Binimetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE41",
            "display": "L01XE41"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-10T00:00:00Z",
            "display": "2017-01-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE41"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XK04",
      "display": "Talazoparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Talazoparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talazoparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX60",
            "display": "Talazoparib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK04",
            "display": "L01XK04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX26",
      "display": "Mirvetuximab soravtansine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mirvetuximab soravtansine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mirvetuksimabsoravtansin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX26",
            "display": "L01FX26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XY03",
      "display": "Nivolumab and relatlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab and relatlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab og relatlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY",
            "display": "Combinations of antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XY03",
            "display": "L01XY03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-09T00:00:00Z",
            "display": "2021-12-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XY03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX85",
      "display": "Idroxioleic acid",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Idroxioleic acid"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Idroksioleinsyre"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX85",
            "display": "L01XX85"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX85"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FY",
      "display": "Combinations of monoclonal antibodies and antibody drug conjugates",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Combinations of monoclonal antibodies and antibody drug conjugates"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kombinasjoner av monoklonale antistoffer og antistoff-legemiddelkonjugater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FY",
            "display": "L01FY"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-14T00:00:00Z",
            "display": "2023-11-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FY"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD02",
      "display": "Docetaxel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Docetaxel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Docetaksel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CD",
            "display": "Taxanes"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD02",
            "display": "L01CD02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BA02",
      "display": "Toremifene",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Toremifene"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Toremifen"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BA",
            "display": "Anti-estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BA02",
            "display": "L02BA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ01",
      "display": "Eculizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Eculizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ekulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA25",
            "display": "Eculizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ01",
            "display": "L04AJ01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC14",
      "display": "Trastuzumab emtansine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab emtansine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumabemtansin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC14",
            "display": "L01XC14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FF02",
      "display": "Pembrolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pembrolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pembrolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC18",
            "display": "Pembrolizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF02",
            "display": "L01FF02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX10",
      "display": "Olaratumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olaratumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olaratumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC27",
            "display": "Olaratumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX10",
            "display": "L01FX10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BX03",
      "display": "Abiraterone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abiraterone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abirateron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BX",
            "display": "Other hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX03",
            "display": "L02BX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-11-02T00:00:00Z",
            "display": "2011-11-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FY02",
      "display": "Nivolumab and relatlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab and relatlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab og relatlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FY",
            "display": "Combinations of monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY03",
            "display": "Nivolumab and relatlimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FY02",
            "display": "L01FY02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FY02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XM01",
      "display": "Enasidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Enasidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enasidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XM",
            "display": "Isocitrate dehydrogenase (IDH) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX59",
            "display": "Enasidenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XM01",
            "display": "L01XM01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-12-08T00:00:00Z",
            "display": "2024-12-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XM01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC18",
      "display": "Risankizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Risankizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Risankizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC18",
            "display": "L04AC18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-03-18T00:00:00Z",
            "display": "2019-03-18T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB04",
      "display": "Osimertinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Osimertinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Osimertinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE35",
            "display": "Osimertinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB04",
            "display": "L01EB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC22",
      "display": "Necitumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Necitumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Necitumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC22",
            "display": "L01XC22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE45",
      "display": "Neratinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Neratinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Neratinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE45",
            "display": "L01XE45"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-03T00:00:00Z",
            "display": "2018-07-03T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE45"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC09",
      "display": "Catumaxomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Catumaxomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Catumaksomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC09",
            "display": "L01XC09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AA05",
      "display": "Chlormethine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Chlormethine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Klormetin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA05",
            "display": "L01AA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX16",
      "display": "Oportuzumab monatox",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Oportuzumab monatox"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Oportuzumab monatoks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX16",
            "display": "L01FX16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH05",
      "display": "Entinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Entinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Entinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX64",
            "display": "Entinostat"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH05",
            "display": "L01XH05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX",
      "display": "Other immunosuppressants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other immunosuppressants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre immunsuppressive midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX",
            "display": "L04AX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG05",
      "display": "Vedolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vedolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vedolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA33",
            "display": "Vedolizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG05",
            "display": "L04AG05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AX",
      "display": "Other hormones",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other hormones"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre hormoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02A",
            "display": "Hormones and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AX",
            "display": "L02AX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FC01",
      "display": "Daratumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Daratumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daratumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FC",
            "display": "CD38 (Clusters of differentitation 38) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC24",
            "display": "Daratumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FC01",
            "display": "L01FC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF04",
      "display": "Avelumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Avelumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Avelumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC31",
            "display": "Avelumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF04",
            "display": "L01FF04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX19",
      "display": "Dasiprotimut-T",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dasiprotimut-T"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dasiprotimut-T"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX19",
            "display": "L03AX19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-07-15T00:00:00Z",
            "display": "2014-07-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD",
      "display": "Nitrosoureas",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nitrosoureas"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nitrosoureaforbindelser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD",
            "display": "L01AD"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX25",
      "display": "Mosunetuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mosunetuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mosunetuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX25",
            "display": "L01FX25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-11-21T00:00:00Z",
            "display": "2022-11-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA17",
      "display": "Adalimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Adalimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Adalimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA17",
            "display": "L04AA17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-01-01T00:00:00Z",
            "display": "2002-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BB02",
      "display": "Mercaptopurine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mercaptopurine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Merkaptopurin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB02",
            "display": "L01BB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BX02",
      "display": "Degarelix",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Degarelix"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Degareliks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BX",
            "display": "Other hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX02",
            "display": "L02BX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD02",
      "display": "Lomustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lomustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lomustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD02",
            "display": "L01AD02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX72",
      "display": "Tazemetostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tazemetostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tazemetostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX72",
            "display": "L01XX72"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX72"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AD02",
      "display": "Tacrolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tacrolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Takrolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AD",
            "display": "Calcineurin inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA05",
            "display": "Tacrolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AD02",
            "display": "L04AD02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AD02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB04",
      "display": "Interferon alfa-2a",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-2a"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-2a"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB04",
            "display": "L03AB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA36",
      "display": "Ocrelizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ocrelizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Okrelizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA36",
            "display": "L04AA36"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-12-21T00:00:00Z",
            "display": "2016-12-21T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA36"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA53",
      "display": "Teprotumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teprotumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teprotumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA53",
            "display": "L04AA53"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA53"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EC01",
      "display": "Vemurafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vemurafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vemurafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EC",
            "display": "B-Raf serine-threonine kinase (BRAF) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE15",
            "display": "Vemurafenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EC01",
            "display": "L01EC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA21",
      "display": "Efalizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Efalizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Efalizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA21",
            "display": "L04AA21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-11-02T00:00:00Z",
            "display": "2004-11-02T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX16",
      "display": "Plerixafor",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Plerixafor"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pleriksafor"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX16",
            "display": "L03AX16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-23T00:00:00Z",
            "display": "2009-03-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE25",
      "display": "Trametinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trametinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trametinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE25",
            "display": "L01XE25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-03-06T00:00:00Z",
            "display": "2013-03-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX46",
      "display": "Olaparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olaparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olaparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX46",
            "display": "L01XX46"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX46"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BC01",
      "display": "Cytarabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cytarabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cytarabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC01",
            "display": "L01BC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BX04",
      "display": "Relugolix",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Relugolix"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Relugoliks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BX",
            "display": "Other hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX04",
            "display": "L02BX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-01-07T00:00:00Z",
            "display": "2022-01-07T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE34",
      "display": "Tivozanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tivozanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tivozanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE34",
            "display": "L01XE34"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE34"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE42",
      "display": "Ribociclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ribociclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ribosiklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE42",
            "display": "L01XE42"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-09-06T00:00:00Z",
            "display": "2016-09-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE42"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02AA",
      "display": "Estrogens",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Estrogens"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Østrogener"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02A",
            "display": "Hormones and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AA",
            "display": "L02AA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA27",
      "display": "Fingolimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fingolimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fingolimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA27",
            "display": "L04AA27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC01",
      "display": "Daclizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Daclizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daklizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA08",
            "display": "Daclizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC01",
            "display": "L04AC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX70",
      "display": "Axicabtagene ciloleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Axicabtagene ciloleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aksikabtagenciloleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX70",
            "display": "L01XX70"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2023-01-13T00:00:00Z",
            "display": "2023-01-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX70"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC26",
      "display": "Goflikicept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Goflikicept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Goflikicept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC26",
            "display": "L04AC26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX28",
      "display": "Glofitamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Glofitamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Glofitamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX28",
            "display": "L01FX28"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-05-10T00:00:00Z",
            "display": "2023-05-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX28"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BX53",
      "display": "Abiraterone and corticosteroids",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abiraterone and corticosteroids"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abirateron og kortikosteroider"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BX",
            "display": "Other hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX53",
            "display": "L02BX53"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX53"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XM02",
      "display": "Ivosidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ivosidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ivosidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XM",
            "display": "Isocitrate dehydrogenase (IDH) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX62",
            "display": "Ivosidenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XM02",
            "display": "L01XM02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-12-08T00:00:00Z",
            "display": "2024-12-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XM02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC20",
      "display": "Netakimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Netakimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Netakimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC20",
            "display": "L04AC20"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC20"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XG02",
      "display": "Carfilzomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carfilzomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karfilzomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XG",
            "display": "Proteasome inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX45",
            "display": "Carfilzomib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XG02",
            "display": "L01XG02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XG02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX10",
      "display": "Midostaurin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Midostaurin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Midostaurin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE39",
            "display": "Midostaurin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX10",
            "display": "L01EX10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG",
      "display": "Monoclonal antibodies",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Monoclonal antibodies"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Monoklonale antistoffer"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG",
            "display": "L04AG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB01",
      "display": "Gefitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gefitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gefitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE02",
            "display": "Gefitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB01",
            "display": "L01EB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA33",
      "display": "Vedolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vedolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vedolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA33",
            "display": "L04AA33"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA33"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EA02",
      "display": "Dasatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dasatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dasatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE06",
            "display": "Dasatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA02",
            "display": "L01EA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX02",
      "display": "Gemtuzumab ozogamicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gemtuzumab ozogamicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gemtuzumabozogamicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC05",
            "display": "Gemtuzumab ozogamicin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX02",
            "display": "L01FX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC37",
      "display": "Polatuzumab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Polatuzumab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Polatuzumabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC37",
            "display": "L01XC37"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-03-02T00:00:00Z",
            "display": "2020-03-02T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC37"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DC04",
      "display": "Ixabepilone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ixabepilone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Iksabepilon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DC",
            "display": "Other cytotoxic antibiotics"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC04",
            "display": "L01DC04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX35",
      "display": "Datopotamab deruxtecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Datopotamab deruxtecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Datopotamabderukstekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX35",
            "display": "L01FX35"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX35"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX77",
      "display": "Adagrasib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Adagrasib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Adagrasib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX77",
            "display": "L01XX77"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX77"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX75",
      "display": "Tebentafusp",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tebentafusp"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tebentafusp"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX75",
            "display": "L01XX75"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-04-25T00:00:00Z",
            "display": "2022-04-25T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX75"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DC02",
      "display": "Plicamycin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Plicamycin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Plikamycin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DC",
            "display": "Other cytotoxic antibiotics"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC02",
            "display": "L01DC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XD01",
      "display": "Porfimer sodium",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Porfimer sodium"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Porfimernatrium"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD01",
            "display": "L01XD01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-06-09T00:00:00Z",
            "display": "2004-06-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD07",
      "display": "Zanidatamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Zanidatamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Zanidatamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD07",
            "display": "L01FD07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE36",
      "display": "Alectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE36",
            "display": "L01XE36"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE36"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE35",
      "display": "Osimertinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Osimertinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Osimertinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE35",
            "display": "L01XE35"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-01-07T00:00:00Z",
            "display": "2016-01-07T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE35"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA01",
      "display": "Ciclosporin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ciclosporin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ciklosporin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA01",
            "display": "L04AA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01A",
      "display": "Alkylating agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alkylating agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alkyleringsmidler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01A",
            "display": "L01A"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01A"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC08",
      "display": "Decitabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Decitabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Decitabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC08",
            "display": "L01BC08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04",
      "display": "Immunosuppressants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Immunosuppressants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Immunsuppressive midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L",
            "display": "Antineoplastic and immunomodulating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04",
            "display": "L04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX56",
      "display": "Etirinotecan pegol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etirinotecan pegol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etirinotekan pegol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX56",
            "display": "L01XX56"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-11T00:00:00Z",
            "display": "2017-01-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX56"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AB01",
      "display": "Interferon alfa natural",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa natural"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Naturlig interferon alfa"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB01",
            "display": "L03AB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE27",
      "display": "Ibrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ibrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ibrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE27",
            "display": "L01XE27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BC07",
      "display": "Azacitidine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Azacitidine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Azacitidin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC07",
            "display": "L01BC07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-02-23T00:00:00Z",
            "display": "2009-02-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AB03",
      "display": "Gestonorone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gestonorone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gestonoron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AB",
            "display": "Progestogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AB03",
            "display": "L02AB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01",
      "display": "Antineoplastic agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastic agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastiske midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L",
            "display": "Antineoplastic and immunomodulating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01",
            "display": "L01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ08",
      "display": "Iptacopan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Iptacopan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Iptakopan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ08",
            "display": "L04AJ08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB03",
      "display": "Afelimomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Afelimomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Afelimomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA16",
            "display": "Afelimomab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB03",
            "display": "L04AB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB14",
      "display": "Cepeginterferon alfa-2b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cepeginterferon alfa-2b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cepeginterferon alfa-2b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB14",
            "display": "L03AB14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB03",
      "display": "Bicalutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bicalutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bikalutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB03",
            "display": "L02BB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AC01",
      "display": "Aldesleukin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aldesleukin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aldesleukin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AC",
            "display": "Interleukins"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AC01",
            "display": "L03AC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ11",
      "display": "Pozelimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pozelimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pozelimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ11",
            "display": "L04AJ11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL10",
      "display": "Nadofaragene firadenovec",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nadofaragene firadenovec"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nadofaragenfiradenovek"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL10",
            "display": "L01XL10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD04",
      "display": "Cabazitaxel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cabazitaxel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kabazitaksel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CD",
            "display": "Taxanes"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD04",
            "display": "L01CD04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-04-15T00:00:00Z",
            "display": "2011-04-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03A",
      "display": "Immunostimulants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Immunostimulants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Immunstimulerende midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03",
            "display": "Immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03A",
            "display": "L03A"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03A"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE29",
      "display": "Lenvatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lenvatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lenvatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE29",
            "display": "L01XE29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-22T00:00:00Z",
            "display": "2015-01-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AE04",
      "display": "Ponesimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ponesimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ponesimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AE",
            "display": "Sphingosine-1-phosphate (S1P) receptor modulators"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA50",
            "display": "Ponesimod"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE04",
            "display": "L04AE04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG04",
      "display": "Letrozole",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Letrozole"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Letrozol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG04",
            "display": "L02BG04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC42",
      "display": "Prolgolimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC42",
            "display": "L01XC42"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-01T00:00:00Z",
            "display": "2022-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC42"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX15",
      "display": "Pexidartinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pexidartinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peksidartinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX15",
            "display": "L01EX15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX03",
      "display": "Catumaxomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Catumaxomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Katumaksomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC09",
            "display": "Catumaxomab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX03",
            "display": "L01FX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB",
      "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Epidermal vekstfaktorreseptor (EGFR) tyrosinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB",
            "display": "L01EB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB11",
      "display": "Peginterferon alfa-2a",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2a"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2a"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB11",
            "display": "L03AB11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-07-25T00:00:00Z",
            "display": "2002-07-25T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BA01",
      "display": "Tamoxifen",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tamoxifen"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tamoksifen"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BA",
            "display": "Anti-estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BA01",
            "display": "L02BA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA11",
      "display": "Etanercept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etanercept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etanercept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA11",
            "display": "L04AA11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EB06",
      "display": "Olmutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olmutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olmutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE40",
            "display": "Olmutinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB06",
            "display": "L01EB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX86",
      "display": "Calaspargase pegol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Calaspargase pegol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kalaspargasepegol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX86",
            "display": "L01XX86"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX86"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA44",
      "display": "Upadacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Upadacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Upadacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA44",
            "display": "L04AA44"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA44"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DC01",
      "display": "Bleomycin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bleomycin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bleomycin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DC",
            "display": "Other cytotoxic antibiotics"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC01",
            "display": "L01DC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX15",
      "display": "Mifamurtide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mifamurtide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mifamurtid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX15",
            "display": "L03AX15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L",
      "display": "Antineoplastic and immunomodulating agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastic and immunomodulating agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastiske og immunmodulerende midler"
        }
      ],
      "property": [
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L",
            "display": "L"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA40",
      "display": "Cladribine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cladribine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kladribin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA40",
            "display": "L04AA40"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA40"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XK",
      "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Poly (ADP-ribose) polymerasehemmere (PARP)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK",
            "display": "L01XK"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AX04",
      "display": "Dacarbazine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dacarbazine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dakarbazin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AX",
            "display": "Other alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AX04",
            "display": "L01AX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB17",
      "display": "Sampeginterferon beta-1A",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sampeginterferon beta-1A"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sampeginterferon beta-1A"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB17",
            "display": "L03AB17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE08",
      "display": "Nilotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nilotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nilotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE08",
            "display": "L01XE08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EN",
      "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fibroblast vekstfaktorreseptor (FGFR) tyrosinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EN",
            "display": "L01EN"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EN"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX18",
      "display": "Tiazofurine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tiazofurine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tiazofurin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX18",
            "display": "L01XX18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE39",
      "display": "Midostaurin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Midostaurin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Midostaurin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE39",
            "display": "L01XE39"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-12-20T00:00:00Z",
            "display": "2016-12-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE39"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AD08",
      "display": "Uramustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Uramustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Uramustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD08",
            "display": "L01AD08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB61",
      "display": "Peginterferon alfa-2a, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2a, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2a, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB61",
            "display": "L03AB61"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-23T00:00:00Z",
            "display": "2009-03-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB61"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX22",
      "display": "Selpercatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Selpercatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Selperkatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX22",
            "display": "L01EX22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE06",
      "display": "Dasatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dasatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dasatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE06",
            "display": "L01XE06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-01-01T00:00:00Z",
            "display": "2007-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC06",
      "display": "Cetuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cetuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cetuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC06",
            "display": "L01XC06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2005-08-02T00:00:00Z",
            "display": "2005-08-02T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BB06",
      "display": "Clofarabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Clofarabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Klofarabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB06",
            "display": "L01BB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-06-27T00:00:00Z",
            "display": "2006-06-27T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX29",
      "display": "Denileukin diftitox",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Denileukin diftitox"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Denileukin diftitoks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX29",
            "display": "L01XX29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-13T00:00:00Z",
            "display": "2002-02-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XF01",
      "display": "Tretinoin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tretinoin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tretinoin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XF",
            "display": "Retinoids for cancer treatment"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX14",
            "display": "Tretinoin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XF01",
            "display": "L01XF01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XF01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE54",
      "display": "Gilteritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gilteritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gilteritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE54",
            "display": "L01XE54"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE54"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE15",
      "display": "Vemurafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vemurafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vemurafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE15",
            "display": "L01XE15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC04",
      "display": "Alemtuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC04",
            "display": "L01XC04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2005-09-15T00:00:00Z",
            "display": "2005-09-15T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2015-01-01T00:00:00Z",
            "display": "2015-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BC03",
      "display": "Tegafur",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tegafur"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tegafur"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC03",
            "display": "L01BC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX27",
      "display": "Epcoritamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Epcoritamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Epkoritamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX27",
            "display": "L01FX27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB",
      "display": "Interferons",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferons"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03A",
            "display": "Immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB",
            "display": "L03AB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EE01",
      "display": "Trametinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trametinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trametinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EE",
            "display": "Mitogen-activated protein kinase (MEK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE25",
            "display": "Trametinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE01",
            "display": "L01EE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CE02",
      "display": "Irinotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Irinotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Irinotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CE",
            "display": "Topoisomerase 1 inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX19",
            "display": "Irinotecan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CE02",
            "display": "L01CE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XK06",
      "display": "Pamiparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pamiparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pamiparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK06",
            "display": "L01XK06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XY04",
      "display": "Bifikafusp alfa and onfekafusp alfa",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bifikafusp alfa and onfekafusp alfa"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bifikafusp alfa og onfekafusp alfa"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY",
            "display": "Combinations of antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XY04",
            "display": "L01XY04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XY04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA19",
      "display": "Eflapegrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Eflapegrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Eflapegrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA19",
            "display": "L03AA19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC35",
      "display": "Tafasitamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tafasitamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tafasitamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC35",
            "display": "L01XC35"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-12T00:00:00Z",
            "display": "2020-10-12T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC35"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XD04",
      "display": "Aminolevulinic acid",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aminolevulinic acid"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aminolevulinsyre"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD04",
            "display": "L01XD04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-06-21T00:00:00Z",
            "display": "2006-06-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA23",
      "display": "Natalizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Natalizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Natalizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA23",
            "display": "L04AA23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-08-11T00:00:00Z",
            "display": "2006-08-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE32",
      "display": "Cediranib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cediranib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cediranib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE32",
            "display": "L01XE32"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE32"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EH01",
      "display": "Lapatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lapatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lapatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EH",
            "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE07",
            "display": "Lapatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EH01",
            "display": "L01EH01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EH01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC25",
      "display": "Mogamulizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mogamulizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mogamulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC25",
            "display": "L01XC25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX13",
      "display": "Gilteritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gilteritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gilteritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE54",
            "display": "Gilteritinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX13",
            "display": "L01EX13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC01",
      "display": "Edrecolomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Edrecolomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Edrekolomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC01",
            "display": "L01XC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FD01",
      "display": "Trastuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC03",
            "display": "Trastuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD01",
            "display": "L01FD01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ09",
      "display": "Danicopan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Danicopan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Danikopan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ09",
            "display": "L04AJ09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA08",
      "display": "Prednimustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Prednimustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Prednimustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA08",
            "display": "L01AA08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC28",
      "display": "Durvalumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Durvalumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Durvalumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC28",
            "display": "L01XC28"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-12-01T00:00:00Z",
            "display": "2017-12-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC28"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AF02",
      "display": "Baricitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Baricitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Baricitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA37",
            "display": "Baricitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF02",
            "display": "L04AF02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX19",
      "display": "Sabatolimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sabatolimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sabatolimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX19",
            "display": "L01FX19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX22",
      "display": "Alitretinoin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alitretinoin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alitretinoin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX22",
            "display": "L01XX22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CB02",
      "display": "Teniposide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teniposide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teniposid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CB",
            "display": "Podophyllotoxin derivatives"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CB02",
            "display": "L01CB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AB",
      "display": "Progestogens",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Progestogens"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Progestogener"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02A",
            "display": "Hormones and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AB",
            "display": "L02AB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX10",
      "display": "Tegomil fumarate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tegomil fumarate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tegomilfumarat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX10",
            "display": "L04AX10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA02",
      "display": "Filgrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Filgrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Filgrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA02",
            "display": "L03AA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA37",
      "display": "Baricitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Baricitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Baricitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA37",
            "display": "L04AA37"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-12-21T00:00:00Z",
            "display": "2016-12-21T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA37"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AA13",
      "display": "Pegfilgrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegfilgrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegfilgrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA13",
            "display": "L03AA13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-03-04T00:00:00Z",
            "display": "2004-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD01",
      "display": "Carmustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carmustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karmustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD01",
            "display": "L01AD01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC02",
      "display": "Fluorouracil",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fluorouracil"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fluorouracil"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC02",
            "display": "L01BC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XD07",
      "display": "Padeliporfin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Padeliporfin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Padeliporfin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD07",
            "display": "L01XD07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-10T00:00:00Z",
            "display": "2017-01-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC07",
      "display": "Bevacizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bevacizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bevacizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC07",
            "display": "L01XC07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2005-02-24T00:00:00Z",
            "display": "2005-02-24T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX10",
      "display": "Immunocyanin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Immunocyanin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Immunocyanin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX10",
            "display": "L03AX10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA15",
      "display": "Balugrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Balugrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Balugrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA15",
            "display": "L03AA15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB01",
      "display": "Etanercept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etanercept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etanercept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA11",
            "display": "Etanercept"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB01",
            "display": "L04AB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ",
      "display": "Complement inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Complement inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Komplementhemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ",
            "display": "L04AJ"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX20",
      "display": "Tremelimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tremelimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tremelimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX20",
            "display": "L01FX20"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-08T00:00:00Z",
            "display": "2021-12-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX20"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE23",
      "display": "Dabrafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dabrafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dabrafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE23",
            "display": "L01XE23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-10-01T00:00:00Z",
            "display": "2013-10-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA26",
      "display": "Belimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA26",
            "display": "L04AA26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA04",
      "display": "Antithymocyte immunoglobulin (rabbit)",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antithymocyte immunoglobulin (rabbit)"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antitymocyttimmunglobulin (kanin)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA04",
            "display": "L04AA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD02",
      "display": "Pertuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC13",
            "display": "Pertuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD02",
            "display": "L01FD02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA49",
      "display": "Peficitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peficitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peficitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA49",
            "display": "L04AA49"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA49"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XL06",
      "display": "Brexucabtagene autoleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brexucabtagene autoleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Breksukabtagenautoleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL06",
            "display": "L01XL06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED",
      "display": "Anaplastic lymphoma kinase (ALK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anaplastic lymphoma kinase (ALK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anaplastisk lymfomkinasehemmere (ALK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED",
            "display": "L01ED"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA10",
      "display": "Melphalan flufenamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Melphalan flufenamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Melfalanflufenamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA10",
            "display": "L01AA10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE01",
      "display": "Imatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Imatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Imatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE01",
            "display": "L01XE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XY02",
      "display": "Pertuzumab and trastuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab and trastuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab og trastuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY",
            "display": "Combinations of antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XY02",
            "display": "L01XY02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XY02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FX13",
      "display": "Enfortumab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Enfortumab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enfortumabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC36",
            "display": "Enfortumab vedotin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX13",
            "display": "L01FX13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC",
      "display": "Pyrimidine analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pyrimidine analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pyrimidinanaloger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01B",
            "display": "Antimetabolites"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC",
            "display": "L01BC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA03",
      "display": "Melphalan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Melphalan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Melfalan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA03",
            "display": "L01AA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XJ",
      "display": "Hedgehog pathway inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Hedgehog pathway inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Hedgehog-signalvei hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XJ",
            "display": "L01XJ"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XJ"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX32",
      "display": "Elranatamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Elranatamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Elranatamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX32",
            "display": "L01FX32"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-03-14T00:00:00Z",
            "display": "2024-03-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX32"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE50",
      "display": "Abemaciclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abemaciclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abemaciklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE50",
            "display": "L01XE50"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE50"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BB04",
      "display": "Cladribine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cladribine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kladribin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB04",
            "display": "L01BB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX01",
      "display": "Edrecolomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Edrecolomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Edrekolomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC01",
            "display": "Edrecolomab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX01",
            "display": "L01FX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FA01",
      "display": "Rituximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rituximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rituksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FA",
            "display": "CD20 (Clusters of differentitation 20) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC02",
            "display": "Rituximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FA01",
            "display": "L01FA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FY01",
      "display": "Pertuzumab and trastuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab and trastuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab og trastuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FY",
            "display": "Combinations of monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY02",
            "display": "Pertuzumab and trastuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FY01",
            "display": "L01FY01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FY01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG14",
      "display": "Ublituximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ublituximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ublituksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA57",
            "display": "Ublituximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG14",
            "display": "L04AG14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-04-12T00:00:00Z",
            "display": "2023-04-12T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XJ03",
      "display": "Glasdegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Glasdegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Glasdegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XJ",
            "display": "Hedgehog pathway inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX63",
            "display": "Glasdegib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XJ03",
            "display": "L01XJ03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XJ03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EL01",
      "display": "Ibrutinibq",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ibrutinibq"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ibrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE27",
            "display": "Ibrutinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL01",
            "display": "L01EL01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FC",
      "display": "CD38 (Clusters of differentitation 38) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "CD38 (Clusters of differentitation 38) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "CD38 (Differensieringsantigen 38) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FC",
            "display": "L01FC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BB07",
      "display": "Nelarabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nelarabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nelarabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB07",
            "display": "L01BB07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE14",
      "display": "Bosutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bosutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bosutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE14",
            "display": "L01XE14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EK",
      "display": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vaskulær endotel vekstfaktorreseptor (VEGFR) tyrosinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EK",
            "display": "L01EK"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EK"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB08",
      "display": "Pirarubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pirarubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pirarubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB08",
            "display": "L01DB08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED03",
      "display": "Alectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01ED",
            "display": "Anaplastic lymphoma kinase (ALK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE36",
            "display": "Alectinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED03",
            "display": "L01ED03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC25",
      "display": "Levilimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Levilimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Levilimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC25",
            "display": "L04AC25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA56",
      "display": "Deucravacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Deucravacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Deukravacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA56",
            "display": "L04AA56"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA56"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FX",
      "display": "Other monoclonal antibodies and antibody drug conjugates",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other monoclonal antibodies and antibody drug conjugates"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre monoklonale antistoffer og antistoff-legemiddelkonjugater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX",
            "display": "L01FX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XD06",
      "display": "Efaproxiral",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Efaproxiral"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Efaproksiral"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD06",
            "display": "L01XD06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC39",
      "display": "Belantamab mafodotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belantamab mafodotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belantamabmafodotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC39",
            "display": "L01XC39"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-08-04T00:00:00Z",
            "display": "2020-08-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC39"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AE",
      "display": "Sphingosine-1-phosphate (S1P) receptor modulators",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sphingosine-1-phosphate (S1P) receptor modulators"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sfingosin-1-fosfat (S1P) reseptormodulatorer"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE",
            "display": "L04AE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC08",
      "display": "Panitumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Panitumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Panitumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC08",
            "display": "L01XC08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-05-08T00:00:00Z",
            "display": "2006-05-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA09",
      "display": "Basiliximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Basiliximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Basiliksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA09",
            "display": "L04AA09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC15",
      "display": "Sirukumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sirukumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sirukumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC15",
            "display": "L04AC15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-12-01T00:00:00Z",
            "display": "2017-12-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG12",
      "display": "Ofatumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA52",
            "display": "Ofatumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG12",
            "display": "L04AG12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX23",
      "display": "Mitotane",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitotane"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitotan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX23",
            "display": "L01XX23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC33",
      "display": "Cemiplimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cemiplimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cemiplimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC33",
            "display": "L01XC33"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC33"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CA04",
      "display": "Vinorelbine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vinorelbine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vinorelbin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA04",
            "display": "L01CA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG16",
      "display": "Rozanolixizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rozanolixizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rozanoliksizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG16",
            "display": "L04AG16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EK04",
      "display": "Fruquintinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fruquintinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Frukvintinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EK",
            "display": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EK04",
            "display": "L01EK04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EK04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XM04",
      "display": "Vorasidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vorasidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vorasidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XM",
            "display": "Isocitrate dehydrogenase (IDH) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XM04",
            "display": "L01XM04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-01-11T00:00:00Z",
            "display": "2024-01-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XM04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE22",
      "display": "Masitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Masitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Masitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE22",
            "display": "L01XE22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-10-03T00:00:00Z",
            "display": "2012-10-03T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AA03",
      "display": "Molgramostim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Molgramostim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Molgramostim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA03",
            "display": "L03AA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX07",
      "display": "Cabozantinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cabozantinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kabozantinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE26",
            "display": "Cabozantinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX07",
            "display": "L01EX07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AX01",
      "display": "Mitobronitol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitobronitol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitobronitol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AX",
            "display": "Other alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AX01",
            "display": "L01AX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX23",
      "display": "Motixafortide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Motixafortide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Motiksafortid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX23",
            "display": "L03AX23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-01-01T00:00:00Z",
            "display": "2025-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AE04",
      "display": "Triptorelin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Triptorelin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Triptorelin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE04",
            "display": "L02AE04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX24",
      "display": "Pegaspargase",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegaspargase"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegaspargase"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX24",
            "display": "L01XX24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX59",
      "display": "Enasidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Enasidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enasidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX59",
            "display": "L01XX59"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2025-01-10T00:00:00Z",
            "display": "2025-01-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX59"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EL04",
      "display": "Orelabrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Orelabrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Orelabrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL04",
            "display": "L01EL04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX58",
      "display": "Epacadostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Epacadostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Epakadostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX58",
            "display": "L01XX58"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX58"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA22",
      "display": "Abetimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abetimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abetimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA22",
            "display": "L04AA22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-08-09T00:00:00Z",
            "display": "2006-08-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX21",
      "display": "Tepotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tepotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tepotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX21",
            "display": "L01EX21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AE",
      "display": "Gonadotropin releasing hormone analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gonadotropin releasing hormone analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gonadotropinfrigjørende hormonanaloger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02A",
            "display": "Hormones and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE",
            "display": "L02AE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XM",
      "display": "Isocitrate dehydrogenase (IDH) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Isocitrate dehydrogenase (IDH) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Isositratdehydrogenase (IDH) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XM",
            "display": "L01XM"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-01-11T00:00:00Z",
            "display": "2024-01-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XM"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX09",
      "display": "Diroximel fumarate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Diroximel fumarate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Diroksimelfumarat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX09",
            "display": "L04AX09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF03",
      "display": "Upadacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Upadacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Upadacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA44",
            "display": "Upadacitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF03",
            "display": "L04AF03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX15",
      "display": "Belantamab mafodotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belantamab mafodotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belantamabmafodotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC39",
            "display": "Belantamab mafodotin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX15",
            "display": "L01FX15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XF02",
      "display": "Alitretinoin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alitretinoin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alitretinoin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XF",
            "display": "Retinoids for cancer treatment"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX22",
            "display": "Alitretinoin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XF02",
            "display": "L01XF02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XF02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE02",
      "display": "Gefitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gefitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gefitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE02",
            "display": "L01XE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-02-11T00:00:00Z",
            "display": "2003-02-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC05",
      "display": "Gemtuzumab ozogamicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gemtuzumab ozogamicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gemtuzumabozogamicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC05",
            "display": "L01XC05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-01-03T00:00:00Z",
            "display": "2006-01-03T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AB13",
      "display": "Peginterferon beta-1a",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon beta-1a"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon beta-1a"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB13",
            "display": "L03AB13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG17",
      "display": "Seniprutug",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Seniprutug"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Seniprutug"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG17",
            "display": "L04AG17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG01",
      "display": "Muromonab-CD3",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Muromonab-CD3"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Muromonab-CD3"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA02",
            "display": "Muromonab-CD3"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG01",
            "display": "L04AG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AE01",
      "display": "Buserelin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Buserelin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Buserelin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE01",
            "display": "L02AE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE03",
      "display": "Erlotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Erlotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Erlotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE03",
            "display": "L01XE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX07",
      "display": "Lonidamine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lonidamine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lonidamin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX07",
            "display": "L01XX07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX11",
      "display": "Tasonermin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tasonermin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tasonermin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX11",
            "display": "L03AX11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA05",
      "display": "Tacrolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tacrolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Takrolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA05",
            "display": "L04AA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EE04",
      "display": "Selumetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Selumetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Selumetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EE",
            "display": "Mitogen-activated protein kinase (MEK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE04",
            "display": "L01EE04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC15",
      "display": "Obinutuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Obinutuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Obinutuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC15",
            "display": "L01XC15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XY",
      "display": "Combinations of antineoplastic agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Combinations of antineoplastic agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kombinasjoner av antineoplastiske midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XY",
            "display": "L01XY"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XY"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX43",
      "display": "Vismodegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vismodegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vismodegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX43",
            "display": "L01XX43"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-01-28T00:00:00Z",
            "display": "2013-01-28T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX43"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EL03",
      "display": "Zanubrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Zanubrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Zanubrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL03",
            "display": "L01EL03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD04",
      "display": "Trastuzumab deruxtecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab deruxtecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumabderukstekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC41",
            "display": "Trastuzumab deruxtecan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD04",
            "display": "L01FD04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX03",
      "display": "Altretamine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Altretamine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Altretamin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX03",
            "display": "L01XX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EN04",
      "display": "Futibatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Futibatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Futibatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EN",
            "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EN04",
            "display": "L01EN04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EN04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA25",
      "display": "Eculizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Eculizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ekulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA25",
            "display": "L04AA25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02BB05",
      "display": "Apalutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Apalutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Apalutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB05",
            "display": "L02BB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FA02",
      "display": "Ofatumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FA",
            "display": "CD20 (Clusters of differentitation 20) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC10",
            "display": "Ofatumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FA02",
            "display": "L01FA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-03T00:00:00Z",
            "display": "2021-12-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AC03",
      "display": "Carboquone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carboquone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karbokon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AC",
            "display": "Ethylene imines"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AC03",
            "display": "L01AC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX08",
      "display": "Elotuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Elotuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Elotuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC23",
            "display": "Elotuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX08",
            "display": "L01FX08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX29",
      "display": "Talquetamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Talquetamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talkvetamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX29",
            "display": "L01FX29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BA",
      "display": "Folic acid analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Folic acid analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Folsyreanaloger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01B",
            "display": "Antimetabolites"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BA",
            "display": "L01BA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CE01",
      "display": "Topotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Topotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Topotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CE",
            "display": "Topoisomerase 1 inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX17",
            "display": "Topotecan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CE01",
            "display": "L01CE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX31",
      "display": "Zolbetuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Zolbetuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Zolbetuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX31",
            "display": "L01FX31"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-08-05T00:00:00Z",
            "display": "2024-08-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX31"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX69",
      "display": "Lurbinectedin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lurbinectedin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lurbinektedin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX69",
            "display": "L01XX69"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX69"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX82",
      "display": "Darinaparsin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Darinaparsin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Darinaparsin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX82",
            "display": "L01XX82"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX82"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01E",
      "display": "Protein kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Protein kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Proteinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01E",
            "display": "L01E"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01E"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX45",
      "display": "Carfilzomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carfilzomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karfilzomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX45",
            "display": "L01XX45"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX45"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX41",
      "display": "Eribulin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Eribulin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Eribulin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX41",
            "display": "L01XX41"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX41"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL09",
      "display": "Tabelecleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tabelecleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tabelekleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL09",
            "display": "L01XL09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-12-22T00:00:00Z",
            "display": "2022-12-22T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX29",
      "display": "Vimseltinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vimseltinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vimseltinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX29",
            "display": "L01EX29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-08-06T00:00:00Z",
            "display": "2025-08-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB04",
      "display": "Adalimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Adalimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Adalimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA17",
            "display": "Adalimumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB04",
            "display": "L04AB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-09-15T00:00:00Z",
            "display": "2003-09-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ10",
      "display": "Vilobelimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vilobelimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vilobelimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ10",
            "display": "L04AJ10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA54",
      "display": "Pegcetacoplan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegcetacoplan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegcetakoplan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA54",
            "display": "L04AA54"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA54"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC24",
      "display": "Mirikizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mirikizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mirikizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC24",
            "display": "L04AC24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-02T00:00:00Z",
            "display": "2023-10-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB06",
      "display": "Darolutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Darolutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Darolutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB06",
            "display": "L02BB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF01",
      "display": "Tofacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tofacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tofacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA29",
            "display": "Tofacitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF01",
            "display": "L04AF01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX39",
      "display": "Romidepsin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Romidepsin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Romidepsin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX39",
            "display": "L01XX39"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX39"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FX24",
      "display": "Teclistamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teclistamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teklistamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX24",
            "display": "L01FX24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-03-10T00:00:00Z",
            "display": "2023-03-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF07",
      "display": "Dostarlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dostarlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dostarlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC40",
            "display": "Dostarlimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF07",
            "display": "L01FF07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA",
      "display": "BCR-ABL tyrosine kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "BCR-ABL tyrosine kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "BCR-ABL tyrosinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA",
            "display": "L01EA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL05",
      "display": "Ciltacabtagene autoleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ciltacabtagene autoleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ciltakabtagenautoleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL05",
            "display": "L01XL05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA35",
      "display": "Begelomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Begelomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Begelomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA35",
            "display": "L04AA35"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA35"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX28",
      "display": "Repotrectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Repotrectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Repotrektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX28",
            "display": "L01EX28"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-01-03T00:00:00Z",
            "display": "2024-01-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX28"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF05",
      "display": "Atezolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Atezolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Atezolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC32",
            "display": "Atezolizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF05",
            "display": "L01FF05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XB01",
      "display": "Procarbazine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Procarbazine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Prokarbazin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XB",
            "display": "Methylhydrazines"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XB01",
            "display": "L01XB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB",
      "display": "Anthracyclines and related substances",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anthracyclines and related substances"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antracykliner og lignende substanser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01D",
            "display": "Cytotoxic antibiotics and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB",
            "display": "L01DB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA43",
      "display": "Ravulizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ravulizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ravulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA43",
            "display": "L04AA43"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA43"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EG",
      "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "(mTOR) kinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EG",
            "display": "L01EG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX27",
      "display": "Capivasertib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Capivasertib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kapivasertib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX27",
            "display": "L01EX27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CC01",
      "display": "Demecolcine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Demecolcine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Demekolcin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CC",
            "display": "Colchicine derivatives"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CC01",
            "display": "L01CC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01D",
      "display": "Cytotoxic antibiotics and related substances",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cytotoxic antibiotics and related substances"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cytotoksiske antibiotika og lignende substanser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01D",
            "display": "L01D"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01D"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB",
      "display": "Anti-androgens",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anti-androgens"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antiandrogener"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02B",
            "display": "Hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB",
            "display": "L02BB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DC05",
      "display": "Utidelone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Utidelone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Utidelon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DC",
            "display": "Other cytotoxic antibiotics"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC05",
            "display": "L01DC05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AB03",
      "display": "Mannosulfan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mannosulfan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mannosulfan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AB",
            "display": "Alkyl sulfonates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AB03",
            "display": "L01AB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AH",
      "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "(mTOR) kinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AH",
            "display": "L04AH"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AH"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG08",
      "display": "Ocrelizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ocrelizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Okrelizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA36",
            "display": "Ocrelizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG08",
            "display": "L04AG08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX71",
      "display": "Tisagenlecleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tisagenlecleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tisagenlekleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX71",
            "display": "L01XX71"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-01-21T00:00:00Z",
            "display": "2020-01-21T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2023-01-13T00:00:00Z",
            "display": "2023-01-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX71"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX09",
      "display": "Thymopentin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Thymopentin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tymopentin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX09",
            "display": "L03AX09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA01",
      "display": "Imatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Imatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Imatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE01",
            "display": "Imatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA01",
            "display": "L01EA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX17",
      "display": "Sipuleucel-T",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sipuleucel-T"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sipuleucel-T"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX17",
            "display": "L03AX17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA60",
      "display": "Remibrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Remibrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Remibrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA60",
            "display": "L04AA60"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA60"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX44",
      "display": "Aflibercept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aflibercept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aflibercept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX44",
            "display": "L01XX44"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-04-29T00:00:00Z",
            "display": "2013-04-29T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX44"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AK01",
      "display": "Leflunomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Leflunomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Leflunomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AK",
            "display": "Dihydroorotate dehydrogenase (DHODH) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA13",
            "display": "Leflunomide"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AK01",
            "display": "L04AK01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AK01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB11",
      "display": "Aumolertinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aumolertinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aumolertinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB11",
            "display": "L01EB11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EE02",
      "display": "Cobimetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cobimetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kobimetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EE",
            "display": "Mitogen-activated protein kinase (MEK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE38",
            "display": "Cobimetinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE02",
            "display": "L01EE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC16",
      "display": "Dinutuximab beta",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dinutuximab beta"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dinutuksimab beta"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC16",
            "display": "L01XC16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-01-06T00:00:00Z",
            "display": "2014-01-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FF06",
      "display": "Cemiplimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cemiplimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cemiplimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC33",
            "display": "Cemiplimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF06",
            "display": "L01FF06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD01",
      "display": "Paclitaxel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Paclitaxel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Paklitaksel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CD",
            "display": "Taxanes"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD01",
            "display": "L01CD01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX38",
      "display": "Vorinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vorinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vorinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX38",
            "display": "L01XX38"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX38"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CE03",
      "display": "Etirinotecan pegol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etirinotecan pegol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etirinotekan pegol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CE",
            "display": "Topoisomerase 1 inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX56",
            "display": "Etirinotecan pegol"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CE03",
            "display": "L01CE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX05",
      "display": "Pidotimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pidotimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pidotimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX05",
            "display": "L03AX05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CA02",
      "display": "Vincristine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vincristine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vinkristin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA02",
            "display": "L01CA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03",
      "display": "Immunostimulants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Immunostimulants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Immunstimulerende midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L",
            "display": "Antineoplastic and immunomodulating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03",
            "display": "L03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA01",
      "display": "Cyclophosphamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cyclophosphamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Syklofosfamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA01",
            "display": "L01AA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE40",
      "display": "Olmutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olmutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olmutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE40",
            "display": "L01XE40"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-12-20T00:00:00Z",
            "display": "2016-12-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE40"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EB03",
      "display": "Afatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Afatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Afatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE13",
            "display": "Afatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB03",
            "display": "L01EB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE44",
      "display": "Lorlatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lorlatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lorlatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE44",
            "display": "L01XE44"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE44"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX03",
      "display": "Pazopanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pazopanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pazopanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE11",
            "display": "Pazopanib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX03",
            "display": "L01EX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA18",
      "display": "Everolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA18",
            "display": "L04AA18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-08-22T00:00:00Z",
            "display": "2003-08-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EG02",
      "display": "Everolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EG",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE10",
            "display": "Everolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EG02",
            "display": "L01EG02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EG02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA05",
      "display": "Polyplatillen",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Polyplatillen"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Polyplatillen"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XA",
            "display": "Platinum compounds"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA05",
            "display": "L01XA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA06",
      "display": "Mycophenolic acid",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mycophenolic acid"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mykofenolsyre"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA06",
            "display": "L04AA06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB06",
      "display": "Idarubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Idarubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Idarubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB06",
            "display": "L01DB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE56",
      "display": "Entrectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Entrectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Entrektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE56",
            "display": "L01XE56"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE56"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX60",
      "display": "Talazoparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Talazoparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talazoparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX60",
            "display": "L01XX60"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-05-04T00:00:00Z",
            "display": "2018-05-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX60"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EL02",
      "display": "Acalabrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Acalabrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Akalabrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE51",
            "display": "Acalabrutinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL02",
            "display": "L01EL02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX12",
      "display": "Melanoma vaccine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Melanoma vaccine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Melanomvaksine"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX12",
            "display": "L03AX12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC34",
      "display": "Moxetumomab pasudotox",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Moxetumomab pasudotox"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Moksetumomabpasudotoks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC34",
            "display": "L01XC34"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-12T00:00:00Z",
            "display": "2020-10-12T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC34"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE48",
      "display": "Icotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Icotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ikotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE48",
            "display": "L01XE48"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE48"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX04",
      "display": "Pegademase",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegademase"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegademase"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX04",
            "display": "L03AX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC13",
      "display": "Pertuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pertuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC13",
            "display": "L01XC13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-01-28T00:00:00Z",
            "display": "2013-01-28T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XG",
      "display": "Proteasome inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Proteasome inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Proteasomhemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XG",
            "display": "L01XG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF01",
      "display": "Nivolumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC17",
            "display": "Nivolumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF01",
            "display": "L01FF01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC13",
      "display": "Ixekizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ixekizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Iksekizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC13",
            "display": "L04AC13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-10T00:00:00Z",
            "display": "2016-02-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC03",
      "display": "Anakinra",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anakinra"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anakinra"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA14",
            "display": "Anakinra"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC03",
            "display": "L04AC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA57",
      "display": "Ublituximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ublituximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ublituksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA57",
            "display": "L04AA57"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-01T00:00:00Z",
            "display": "2024-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA57"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE",
      "display": "Protein kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Protein kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Proteinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE",
            "display": "L01XE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-01-15T00:00:00Z",
            "display": "2021-01-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE31",
      "display": "Nintedanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nintedanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nintedanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE31",
            "display": "L01XE31"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-12-04T00:00:00Z",
            "display": "2014-12-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE31"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01F",
      "display": "Monoclonal antibodies and antibody drug conjugates",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Monoclonal antibodies and antibody drug conjugates"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Monoklonale antistoffer og antistoff-legemiddelkonjugater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01F",
            "display": "L01F"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01F"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB02",
      "display": "Nilutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nilutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nilutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB02",
            "display": "L02BB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL01",
      "display": "Sitimagene ceradenovec",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sitimagene ceradenovec"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sitimagenceradenovek"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX37",
            "display": "Sitimagene ceradenovec"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL01",
            "display": "L01XL01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-09-09T00:00:00Z",
            "display": "2022-09-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG06",
      "display": "Alemtuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA34",
            "display": "Alemtuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG06",
            "display": "L04AG06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA02",
      "display": "Muromonab-CD3",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Muromonab-CD3"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Muromonab-CD3"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA02",
            "display": "L04AA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EF02",
      "display": "Ribociclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ribociclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ribosiklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EF",
            "display": "Cyclin-dependent kinases (CDK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE42",
            "display": "Ribociclib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EF02",
            "display": "L01EF02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EF02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX02",
      "display": "Sorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE05",
            "display": "Sorafenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX02",
            "display": "L01EX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX17",
      "display": "Sacituzumab govitecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sacituzumab govitecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sacituzumabgovitekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX17",
            "display": "L01FX17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-10-26T00:00:00Z",
            "display": "2021-10-26T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FE01",
      "display": "Cetuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cetuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cetuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FE",
            "display": "EGFR (Epidermal growth factor receptor) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC06",
            "display": "Cetuximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FE01",
            "display": "L01FE01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FE01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA18",
      "display": "Efbemalenograstim alfa",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Efbemalenograstim alfa"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Efbemalenograstim alfa"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA18",
            "display": "L03AA18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC04",
      "display": "Rilonacept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rilonacept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rilonacept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC04",
            "display": "L04AC04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-23T00:00:00Z",
            "display": "2009-03-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX06",
      "display": "Dinutuximab beta",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dinutuximab beta"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dinutuksimab beta"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC16",
            "display": "Dinutuximab beta"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX06",
            "display": "L01FX06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE16",
      "display": "Crizotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Crizotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Krizotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE16",
            "display": "L01XE16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DA01",
      "display": "Dactinomycin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dactinomycin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daktinomycin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DA",
            "display": "Actinomycines"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DA01",
            "display": "L01DA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB05",
      "display": "Zorubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Zorubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Zorubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB05",
            "display": "L01DB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EM03",
      "display": "Alpelisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alpelisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alpelisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EM",
            "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX65",
            "display": "Alpelisib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM03",
            "display": "L01EM03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AD",
      "display": "Calcineurin inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Calcineurin inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kalsineurinhemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AD",
            "display": "L04AD"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AD"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BB03",
      "display": "Tioguanine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tioguanine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tioguanin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB03",
            "display": "L01BB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB09",
      "display": "Interferon alfacon-1",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfacon-1"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfakon-1"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB09",
            "display": "L03AB09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA17",
      "display": "Pegteograstim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegteograstim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegteograstim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA17",
            "display": "L03AA17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-11T00:00:00Z",
            "display": "2017-01-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AE51",
      "display": "Leuprorelin and bicalutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Leuprorelin and bicalutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Leuprorelin og bikalutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE51",
            "display": "L02AE51"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE51"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC",
      "display": "Monoclonal antibodies",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Monoclonal antibodies"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Monoklonale antistoffer"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC",
            "display": "L01XC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-19T00:00:00Z",
            "display": "2022-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX05",
      "display": "Regorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Regorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Regorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE21",
            "display": "Regorafenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX05",
            "display": "L01EX05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG03",
      "display": "Natalizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Natalizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Natalizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA23",
            "display": "Natalizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG03",
            "display": "L04AG03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC17",
      "display": "Nivolumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nivolumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC17",
            "display": "L01XC17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-22T00:00:00Z",
            "display": "2015-01-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX14",
      "display": "Tretinoin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tretinoin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tretinoin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX14",
            "display": "L01XX14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FX18",
      "display": "Amivantamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Amivantamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Amivantamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX18",
            "display": "L01FX18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-01T00:00:00Z",
            "display": "2021-11-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XK05",
      "display": "Veliparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Veliparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Veliparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK05",
            "display": "L01XK05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE17",
      "display": "Axitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Axitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aksitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE17",
            "display": "L01XE17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EB08",
      "display": "Icotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Icotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ikotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE48",
            "display": "Icotinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB08",
            "display": "L01EB08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE37",
      "display": "Rociletinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rociletinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rociletinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE37",
            "display": "L01XE37"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE37"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX65",
      "display": "Alpelisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alpelisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alpelisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX65",
            "display": "L01XX65"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX65"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC18",
      "display": "Pembrolizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pembrolizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pembrolizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC18",
            "display": "L01XC18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-10-01T00:00:00Z",
            "display": "2014-10-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX24",
      "display": "Mavorixafor",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mavorixafor"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mavoriksafor"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX24",
            "display": "L03AX24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-01-01T00:00:00Z",
            "display": "2025-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EJ04",
      "display": "Momelotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Momelotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Momelotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EJ",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EJ04",
            "display": "L01EJ04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EJ04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE51",
      "display": "Acalabrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Acalabrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Akalabrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE51",
            "display": "L01XE51"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE51"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX49",
      "display": "Belinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX49",
            "display": "L01XX49"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-22T00:00:00Z",
            "display": "2015-01-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX49"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EB09",
      "display": "Lazertinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lazertinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lazertinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB09",
            "display": "L01EB09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-05T00:00:00Z",
            "display": "2022-05-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC",
      "display": "Interleukin inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interleukin inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interleukinhemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC",
            "display": "L04AC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XD03",
      "display": "Methyl aminolevulinate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Methyl aminolevulinate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Metylaminolevulinat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD03",
            "display": "L01XD03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-05-31T00:00:00Z",
            "display": "2006-05-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FE02",
      "display": "Panitumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Panitumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Panitumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FE",
            "display": "EGFR (Epidermal growth factor receptor) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC08",
            "display": "Panitumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FE02",
            "display": "L01FE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX07",
      "display": "Dimethyl fumarate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dimethyl fumarate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dimetylfumarat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/f7949a93-d26e-4235-ac5d-d2b898a7aad4",
            "code": "N07XX09",
            "display": "Dimethyl fumarate"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX07",
            "display": "L04AX07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-12-20T00:00:00Z",
            "display": "2018-12-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD",
      "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "HER2 (Epidermal vekstfaktorreseptor 2, human) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD",
            "display": "L01FD"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX51",
      "display": "Talimogene laherparepvec",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Talimogene laherparepvec"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talimogenlaherparepvek"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX51",
            "display": "L01XX51"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-10T00:00:00Z",
            "display": "2016-02-10T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2023-01-13T00:00:00Z",
            "display": "2023-01-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX51"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC36",
      "display": "Enfortumab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Enfortumab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enfortumabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC36",
            "display": "L01XC36"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC36"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02AE03",
      "display": "Goserelin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Goserelin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Goserelin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE03",
            "display": "L02AE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02",
      "display": "Endocrine therapy",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Endocrine therapy"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Endokrin terapi"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L",
            "display": "Antineoplastic and immunomodulating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02",
            "display": "L02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB10",
      "display": "Peginterferon alfa-2b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfa-2b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB10",
            "display": "L03AB10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XJ01",
      "display": "Vismodegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vismodegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vismodegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XJ",
            "display": "Hedgehog pathway inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX43",
            "display": "Vismodegib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XJ01",
            "display": "L01XJ01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XJ01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA09",
      "display": "Bendamustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bendamustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bendamustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA09",
            "display": "L01AA09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE10",
      "display": "Everolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE10",
            "display": "L01XE10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02BG03",
      "display": "Anastrozole",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anastrozole"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anastrozol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG03",
            "display": "L02BG03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC11",
      "display": "Ipilimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ipilimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ipilimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC11",
            "display": "L01XC11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-09-22T00:00:00Z",
            "display": "2011-09-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC10",
      "display": "Secukinumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Secukinumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sekukinumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC10",
            "display": "L04AC10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01B",
      "display": "Antimetabolites",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antimetabolites"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antimetabolitter"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01B",
            "display": "L01B"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01B"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH",
      "display": "Histone deacetylase (HDAC) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Histone deacetylase (HDAC) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Histondeacetylasehemmere (HDAC)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH",
            "display": "L01XH"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA61",
      "display": "Nerandomilast",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nerandomilast"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nerandomilast"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA61",
            "display": "L04AA61"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-04-30T00:00:00Z",
            "display": "2025-04-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA61"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent (internt)",
            "display": "Godkjent (internt)"
          }
        }
      ]
    },
    {
      "code": "L01BC59",
      "display": "Trifluridine, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trifluridine, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trifluridin, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC59",
            "display": "L01BC59"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-07-15T00:00:00Z",
            "display": "2014-07-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC59"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA",
      "display": "Selective immunosuppressants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Selective immunosuppressants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Selektive immunsuppressive midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA",
            "display": "L04AA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ04",
      "display": "Sutimlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sutimlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sutimlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA55",
            "display": "Sutimlimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ04",
            "display": "L04AJ04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA03",
      "display": "Oxaliplatin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Oxaliplatin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Oksaliplatin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XA",
            "display": "Platinum compounds"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA03",
            "display": "L01XA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL",
      "display": "Antineoplastic cell and gene therapy",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastic cell and gene therapy"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antineoplastisk celle- og genterapi"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL",
            "display": "L01XL"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX08",
      "display": "Pentostatin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pentostatin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pentostatin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX08",
            "display": "L01XX08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AK02",
      "display": "Teriflunomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teriflunomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teriflunomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AK",
            "display": "Dihydroorotate dehydrogenase (DHODH) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA31",
            "display": "Teriflunomide"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AK02",
            "display": "L04AK02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AK02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC11",
      "display": "Siltuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Siltuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Siltuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC11",
            "display": "L04AC11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-05-12T00:00:00Z",
            "display": "2014-05-12T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX68",
      "display": "Belotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX68",
            "display": "L01XX68"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX68"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AB01",
      "display": "Busulfan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Busulfan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Busulfan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AB",
            "display": "Alkyl sulfonates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AB01",
            "display": "L01AB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX36",
      "display": "Patritumab deruxtecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Patritumab deruxtecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Patritumabderukstekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX36",
            "display": "L01FX36"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX36"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX78",
      "display": "Navitoclax",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Navitoclax"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Navitoklaks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX78",
            "display": "L01XX78"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX78"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AC",
      "display": "Interleukins",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interleukins"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interleukiner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03A",
            "display": "Immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AC",
            "display": "L03AC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX02",
      "display": "Roquinimex",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Roquinimex"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rokinimeks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX02",
            "display": "L03AX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA10",
      "display": "Sirolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA10",
            "display": "L04AA10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02B",
      "display": "Hormone antagonists and related agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Hormone antagonists and related agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Hormonantagonister og beslektede substanser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02",
            "display": "Endocrine therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02B",
            "display": "L02B"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02B"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC53",
      "display": "Tegafur, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tegafur, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tegafur, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC53",
            "display": "L01BC53"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC53"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AX02",
      "display": "Pipobroman",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pipobroman"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pipobroman"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AX",
            "display": "Other alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AX02",
            "display": "L01AX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF09",
      "display": "Tislelizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tislelizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tislelizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF09",
            "display": "L01FF09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC22",
      "display": "Spesolimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Spesolimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Spesolimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC22",
            "display": "L04AC22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD04",
      "display": "Streptozocin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Streptozocin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Streptozocin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD04",
            "display": "L01AD04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC19",
      "display": "Blinatumomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Blinatumomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Blinatumomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC19",
            "display": "L01XC19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-22T00:00:00Z",
            "display": "2015-01-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FF11",
      "display": "Sugemalimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sugemalimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sugemalimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF11",
            "display": "L01FF11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA06",
      "display": "Ifosfamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ifosfamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ifosfamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA06",
            "display": "L01AA06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CC",
      "display": "Colchicine derivatives",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Colchicine derivatives"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kolkisinderivater"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CC",
            "display": "L01CC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AA02",
      "display": "Polyestradiol phosphate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Polyestradiol phosphate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Polyøstradiolfosfat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AA",
            "display": "Estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AA02",
            "display": "L02AA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA16",
      "display": "Empegfilgrastim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Empegfilgrastim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Empegfilgrastim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA16",
            "display": "L03AA16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC05",
      "display": "Ustekinumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ustekinumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ustekinumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC05",
            "display": "L04AC05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-23T00:00:00Z",
            "display": "2009-03-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XY01",
      "display": "Cytarabine and daunorubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cytarabine and daunorubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cytarabin og daunorubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XY",
            "display": "Combinations of antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XY01",
            "display": "L01XY01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XY01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX19",
      "display": "Irinotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Irinotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Irinotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX19",
            "display": "L01XX19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FE",
      "display": "EGFR (Epidermal growth factor receptor) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "EGFR (Epidermal growth factor receptor) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "EGFR (Epidermal vekstfaktorreseptor) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FE",
            "display": "L01FE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EJ01",
      "display": "Ruxolitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ruxolitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ruksolitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EJ",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE18",
            "display": "Ruxolitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EJ01",
            "display": "L01EJ01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EJ01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF03",
      "display": "Durvalumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Durvalumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Durvalumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC28",
            "display": "Durvalumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF03",
            "display": "L01FF03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AG",
      "display": "Epoxides",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Epoxides"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Epoksider"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AG",
            "display": "L01AG"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AG"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EF",
      "display": "Cyclin-dependent kinases (CDK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cyclin-dependent kinases (CDK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cyklinavhengige kinasehemmere (CDK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EF",
            "display": "L01EF"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EF"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AE05",
      "display": "Etrasimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etrasimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etrasimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AE",
            "display": "Sphingosine-1-phosphate (S1P) receptor modulators"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AE05",
            "display": "L04AE05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AE05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX20",
      "display": "Pemigatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pemigatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pemigatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX20",
            "display": "L01EX20"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX20"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FX07",
      "display": "Blinatumomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Blinatumomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Blinatumomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC19",
            "display": "Blinatumomab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX07",
            "display": "L01FX07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG15",
      "display": "Divozilimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Divozilimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Divozilimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG15",
            "display": "L04AG15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE12",
      "display": "Vandetanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vandetanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vandetanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE12",
            "display": "L01XE12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX09",
      "display": "Nintedanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nintedanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nintedanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE31",
            "display": "Nintedanib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX09",
            "display": "L01EX09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB02",
      "display": "Infliximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Infliximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Infliksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA12",
            "display": "Infliximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB02",
            "display": "L04AB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AD01",
      "display": "Ciclosporin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ciclosporin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ciklosporin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AD",
            "display": "Calcineurin inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA01",
            "display": "Ciclosporin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AD01",
            "display": "L04AD01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AD01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX61",
      "display": "Copanlisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Copanlisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kopanlisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX61",
            "display": "L01XX61"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX61"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DB07",
      "display": "Mitoxantrone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitoxantrone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitoksantron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB07",
            "display": "L01DB07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB10",
      "display": "Mobocertinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mobocertinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mobosertinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB10",
            "display": "L01EB10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA",
      "display": "Colony stimulating factors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Colony stimulating factors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kolonistimulerende midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03A",
            "display": "Immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA",
            "display": "L03AA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX34",
      "display": "Odronextamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Odronextamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Odronekstamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX34",
            "display": "L01FX34"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX34"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ07",
      "display": "Crovalimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Crovalimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Krovalimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ07",
            "display": "L04AJ07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF04",
      "display": "Filgotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Filgotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Filgotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA45",
            "display": "Filgotinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF04",
            "display": "L04AF04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01X",
      "display": "Other antineoplastic agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other antineoplastic agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre antineoplastiske midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01X",
            "display": "L01X"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01X"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX33",
      "display": "Tarlatamab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tarlatamab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tarlatamab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX33",
            "display": "L01FX33"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX33"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01C",
      "display": "Plant alkaloids and other natural products",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Plant alkaloids and other natural products"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Plantealkaloider og andre naturprodukter"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01",
            "display": "Antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01C",
            "display": "L01C"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01C"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EM01",
      "display": "Idelalisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Idelalisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Idelalisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EM",
            "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX47",
            "display": "Idelalisib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM01",
            "display": "L01EM01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX26",
      "display": "Sitravatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sitravatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sitravatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX26",
            "display": "L01EX26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF06",
      "display": "Peficitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peficitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peficitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA49",
            "display": "Peficitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF06",
            "display": "L04AF06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX52",
      "display": "Venetoclax",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Venetoclax"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Venetoklaks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX52",
            "display": "L01XX52"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-11-21T00:00:00Z",
            "display": "2015-11-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX52"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA45",
      "display": "Filgotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Filgotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Filgotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA45",
            "display": "L04AA45"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-04T00:00:00Z",
            "display": "2020-10-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA45"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02AE05",
      "display": "Histrelin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Histrelin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Histrelin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/bd343711-ab45-4ebd-9f2c-b128f422645e",
            "code": "H01CA03",
            "display": "Histrelin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE05",
            "display": "L02AE05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-12-21T00:00:00Z",
            "display": "2012-12-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG07",
      "display": "Begelomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Begelomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Begelomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA35",
            "display": "Begelomab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG07",
            "display": "L04AG07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ03",
      "display": "Pegcetacoplan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pegcetacoplan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pegcetakoplan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA54",
            "display": "Pegcetacoplan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ03",
            "display": "L04AJ03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB06",
      "display": "Interferon alfa-n1",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-n1"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-n1"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB06",
            "display": "L03AB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX17",
      "display": "Topotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Topotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Topotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX17",
            "display": "L01XX17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FF13",
      "display": "Toripalimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Toripalimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Toripalimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF13",
            "display": "L01FF13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC05",
      "display": "Gemcitabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gemcitabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gemcitabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC05",
            "display": "L01BC05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EC",
      "display": "B-Raf serine-threonine kinase (BRAF) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "B-Raf serine-threonine kinase (BRAF) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "B-Raf serin-treoninkinasehemmere (BRAF)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EC",
            "display": "L01EC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF10",
      "display": "Retifanlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Retifanlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Retifanlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF10",
            "display": "L01FF10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EL05",
      "display": "Pirtobrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pirtobrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pirtobrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL05",
            "display": "L01EL05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC03",
      "display": "Trastuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC03",
            "display": "L01XC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EE",
      "display": "Mitogen-activated protein kinase (MEK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitogen-activated protein kinase (MEK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitogenaktiverte proteinkinasehemmere (MEK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE",
            "display": "L01EE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA12",
      "display": "Ancestim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ancestim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ancestim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA12",
            "display": "L03AA12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX73",
      "display": "Sotorasib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sotorasib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sotorasib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX73",
            "display": "L01XX73"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX73"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX57",
      "display": "Plitidepsin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Plitidepsin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Plitidepsin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX57",
            "display": "L01XX57"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-11T00:00:00Z",
            "display": "2017-01-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX57"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA12",
      "display": "Infliximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Infliximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Infliksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA12",
            "display": "L04AA12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX21",
      "display": "Elapegademase",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Elapegademase"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Elapegademase"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX21",
            "display": "L03AX21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-08-20T00:00:00Z",
            "display": "2020-08-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX74",
      "display": "Belzutifan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belzutifan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belzutifan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX74",
            "display": "L01XX74"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX74"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EL",
      "display": "Bruton's tyrosine kinase (BTK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bruton's tyrosine kinase (BTK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brutons tyrosinkinasehemmere (BTK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL",
            "display": "L01EL"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA34",
      "display": "Alemtuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alemtuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC04",
            "display": "Alemtuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA34",
            "display": "L04AA34"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-01T00:00:00Z",
            "display": "2015-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA34"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC09",
      "display": "Briakinumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Briakinumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Briakinumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC09",
            "display": "L04AC09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-10-12T00:00:00Z",
            "display": "2010-10-12T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX16",
      "display": "Mitoguazone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitoguazone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitoguazon"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX16",
            "display": "L01XX16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX37",
      "display": "Sitimagene ceradenovec",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sitimagene ceradenovec"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sitimagenseradenovek"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX37",
            "display": "L01XX37"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2023-01-13T00:00:00Z",
            "display": "2023-01-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX37"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA16",
      "display": "Afelimomab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Afelimomab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Afelimomab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA16",
            "display": "L04AA16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX",
      "display": "Other immunostimulants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other immunostimulants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre immunstimulerende midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03A",
            "display": "Immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX",
            "display": "L03AX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA04",
      "display": "Bosutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bosutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bosutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE14",
            "display": "Bosutinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA04",
            "display": "L01EA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA29",
      "display": "Tofacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tofacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tofacitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA29",
            "display": "L04AA29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-01-29T00:00:00Z",
            "display": "2013-01-29T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DC03",
      "display": "Mitomycin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mitomycin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mitomycin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DC",
            "display": "Other cytotoxic antibiotics"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC03",
            "display": "L01DC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX80",
      "display": "Imetelstat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Imetelstat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Imetelstat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX80",
            "display": "L01XX80"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX80"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD06",
      "display": "Margetuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Margetuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Margetuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD06",
            "display": "L01FD06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL11",
      "display": "Lifileucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lifileucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lifileucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL11",
            "display": "L01XL11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH07",
      "display": "Resminostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Resminostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Resminostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH07",
            "display": "L01XH07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BA03",
      "display": "Fulvestrant",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fulvestrant"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fulvestrant"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BA",
            "display": "Anti-estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BA03",
            "display": "L02BA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-03-12T00:00:00Z",
            "display": "2003-03-12T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EH02",
      "display": "Neratinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Neratinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Neratinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EH",
            "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE45",
            "display": "Neratinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EH02",
            "display": "L01EH02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EH02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX48",
      "display": "Sonidegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sonidegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sonidegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX48",
            "display": "L01XX48"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-01-22T00:00:00Z",
            "display": "2015-01-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX48"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FF12",
      "display": "Serplulimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Serplulimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Serplulimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF12",
            "display": "L01FF12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ06",
      "display": "Zilucoplan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Zilucoplan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Zilukoplan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ06",
            "display": "L04AJ06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FC02",
      "display": "Isatuximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Isatuximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Isatuksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FC",
            "display": "CD38 (Clusters of differentitation 38) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC38",
            "display": "Isatuximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FC02",
            "display": "L01FC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX32",
      "display": "Bortezomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bortezomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bortezomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX32",
            "display": "L01XX32"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-07-01T00:00:00Z",
            "display": "2004-07-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX32"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BC06",
      "display": "Capecitabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Capecitabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kapecitabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC06",
            "display": "L01BC06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AJ05",
      "display": "Avacopan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Avacopan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Avakopan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA59",
            "display": "Avacopan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ05",
            "display": "L04AJ05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB",
      "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tumornekrosefaktor alfa (TNF-alfa)-hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB",
            "display": "L04AB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB16",
      "display": "Peginterferon alfacon-2",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfacon-2"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Peginterferon alfakon-2"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB16",
            "display": "L03AB16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE09",
      "display": "Temsirolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Temsirolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Temsirolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE09",
            "display": "L01XE09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-05-22T00:00:00Z",
            "display": "2008-05-22T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC12",
      "display": "Brodalumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brodalumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brodalumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC12",
            "display": "L04AC12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CE04",
      "display": "Belotecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belotecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belotekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CE",
            "display": "Topoisomerase 1 inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX68",
            "display": "Belotecan"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CE04",
            "display": "L01CE04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CE04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX11",
      "display": "Bermekimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bermekimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bermekimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC29",
            "display": "Bermekimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX11",
            "display": "L01FX11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX01",
      "display": "Amsacrine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Amsacrine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Amsakrin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX01",
            "display": "L01XX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA01",
      "display": "Cisplatin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cisplatin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cisplatin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XA",
            "display": "Platinum compounds"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA01",
            "display": "L01XA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AE02",
      "display": "Leuprorelin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Leuprorelin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Leuprorelin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AE",
            "display": "Gonadotropin releasing hormone analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AE02",
            "display": "L02AE02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AE02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX24",
      "display": "Surufatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Surufatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Surufatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX24",
            "display": "L01EX24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC04",
      "display": "Carmofur",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carmofur"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karmofur"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC04",
            "display": "L01BC04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EN01",
      "display": "Erdafitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Erdafitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Erdafitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EN",
            "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX16",
            "display": "Erdafitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EN01",
            "display": "L01EN01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-04-07T00:00:00Z",
            "display": "2022-04-07T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EN01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE11",
      "display": "Pazopanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pazopanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pazopanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE11",
            "display": "L01XE11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX14",
      "display": "Entrectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Entrectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Entrektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE56",
            "display": "Entrectinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX14",
            "display": "L01EX14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DC",
      "display": "Other cytotoxic antibiotics",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other cytotoxic antibiotics"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre cytotoksiske antibiotika"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01D",
            "display": "Cytotoxic antibiotics and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DC",
            "display": "L01DC"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DC"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BA03",
      "display": "Raltitrexed",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Raltitrexed"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Raltitreksed"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BA",
            "display": "Folic acid analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BA03",
            "display": "L01BA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA24",
      "display": "Abatacept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abatacept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abatacept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA24",
            "display": "L04AA24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-01-01T00:00:00Z",
            "display": "2007-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA05",
      "display": "Ponatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ponatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ponatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE24",
            "display": "Ponatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA05",
            "display": "L01EA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EM",
      "display": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fosfatidylinositol-3-kinasehemmere (Pi3K)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EM",
            "display": "L01EM"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EM"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX23",
      "display": "Pralsetinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pralsetinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pralsetinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX23",
            "display": "L01EX23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC02",
      "display": "Rituximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rituximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rituksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC02",
            "display": "L01XC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AB07",
      "display": "Interferon beta-1a",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon beta-1a"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon beta-1a"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB07",
            "display": "L03AB07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EH03",
      "display": "Tucatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tucatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tukatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EH",
            "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EH03",
            "display": "L01EH03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EH03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG13",
      "display": "Teprotumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teprotumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teprotumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA53",
            "display": "Teprotumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG13",
            "display": "L04AG13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX08",
      "display": "Lenvatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lenvatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lenvatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE29",
            "display": "Lenvatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX08",
            "display": "L01EX08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB04",
      "display": "Aclarubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aclarubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aklarubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB04",
            "display": "L01DB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CA03",
      "display": "Vindesine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vindesine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vindesin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA03",
            "display": "L01CA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX19",
      "display": "Ripretinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ripretinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ripretinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX19",
            "display": "L01EX19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC41",
      "display": "Trastuzumab deruxtecan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab deruxtecan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumabderukstekan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC41",
            "display": "L01XC41"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC41"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AJ02",
      "display": "Ravulizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ravulizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ravulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AJ",
            "display": "Complement inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA43",
            "display": "Ravulizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AJ02",
            "display": "L04AJ02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AJ02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC23",
      "display": "Elotuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Elotuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Elotuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC23",
            "display": "L01XC23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE07",
      "display": "Lapatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lapatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lapatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE07",
            "display": "L01XE07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02BX",
      "display": "Other hormone antagonists and related agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other hormone antagonists and related agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre hormonantagonister og beslektede substanser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02B",
            "display": "Hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BX",
            "display": "L02BX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EJ",
      "display": "Janus-associated kinase (JAK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Janus-associated kinase (JAK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Janus-assosierte kinasehemmere (JAK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EJ",
            "display": "L01EJ"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EJ"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA15",
      "display": "Alefacept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Alefacept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Alefacept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA15",
            "display": "L04AA15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC24",
      "display": "Daratumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Daratumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daratumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC24",
            "display": "L01XC24"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC24"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XC27",
      "display": "Olaratumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olaratumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olaratumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC27",
            "display": "L01XC27"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-09-26T00:00:00Z",
            "display": "2016-09-26T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC27"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FB02",
      "display": "Moxetumomab pasudotox",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Moxetumomab pasudotox"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Moksetumomabpasudotoks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FB",
            "display": "CD22 (Clusters of differentitation 22) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC34",
            "display": "Moxetumomab pasudotox"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FB02",
            "display": "L01FB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA02",
      "display": "Carboplatin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Carboplatin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Karboplatin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XA",
            "display": "Platinum compounds"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA02",
            "display": "L01XA02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CA05",
      "display": "Vinflunine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vinflunine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vinflunin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA05",
            "display": "L01CA05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CX",
      "display": "Other plant alkaloids and natural products",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other plant alkaloids and natural products"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre plantealkaloider og naturprodukter"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CX",
            "display": "L01CX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD03",
      "display": "Paclitaxel poliglumex",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Paclitaxel poliglumex"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Paklitakselpoliglumeks"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CD",
            "display": "Taxanes"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD03",
            "display": "L01CD03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX53",
      "display": "Vosaroxin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vosaroxin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vosaroksin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX53",
            "display": "L01XX53"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-12-20T00:00:00Z",
            "display": "2016-12-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX53"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX18",
      "display": "Cridanimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cridanimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kridanimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX18",
            "display": "L03AX18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BA04",
      "display": "Elacestrant",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Elacestrant"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Elacestrant"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BA",
            "display": "Anti-estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BA04",
            "display": "L02BA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA14",
      "display": "Anakinra",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anakinra"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anakinra"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA14",
            "display": "L04AA14"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-02-12T00:00:00Z",
            "display": "2003-02-12T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA14"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AX07",
      "display": "Poly I:C",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Poly I:C"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Poly I:C"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX07",
            "display": "L03AX07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX25",
      "display": "Umbralisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Umbralisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Umbralisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX25",
            "display": "L01EX25"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX25"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH01",
      "display": "Vorinostat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vorinostat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vorinostat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX38",
            "display": "Vorinostat"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH01",
            "display": "L01XH01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA42",
      "display": "Siponimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Siponimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Siponimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA42",
            "display": "L04AA42"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA42"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA39",
      "display": "Emapalumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Emapalumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Emapalumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA39",
            "display": "L04AA39"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA39"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AX",
      "display": "Other alkylating agents",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Other alkylating agents"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Andre alkyleringsmidler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01A",
            "display": "Alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AX",
            "display": "L01AX"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AX"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF08",
      "display": "Prolgolimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FF",
            "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC42",
            "display": "Prolgolimab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF08",
            "display": "L01FF08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA",
      "display": "Platinum compounds",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Platinum compounds"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Platinaforbindelser"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA",
            "display": "L01XA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB09",
      "display": "Valrubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Valrubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Valrubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB09",
            "display": "L01DB09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX63",
      "display": "Glasdegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Glasdegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Glasdegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX63",
            "display": "L01XX63"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX63"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01AX03",
      "display": "Temozolomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Temozolomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Temozolomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AX",
            "display": "Other alkylating agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AX03",
            "display": "L01AX03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AX03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XA04",
      "display": "Satraplatin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Satraplatin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Satraplatin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XA",
            "display": "Platinum compounds"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XA04",
            "display": "L01XA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-20T00:00:00Z",
            "display": "2009-03-20T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA48",
      "display": "Belumosudil",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belumosudil"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belumosudil"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA48",
            "display": "L04AA48"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA48"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FF",
      "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "PD-1/PDL-1 (Programmert celledødprotein 1/celledødligand 1) hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01F",
            "display": "Monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FF",
            "display": "L01FF"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-05-03T00:00:00Z",
            "display": "2021-05-03T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FF"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX23",
      "display": "Tisotumab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tisotumab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tisotumabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX23",
            "display": "L01FX23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX47",
      "display": "Idelalisib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Idelalisib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Idelalisib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX47",
            "display": "L01XX47"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-02-20T00:00:00Z",
            "display": "2014-02-20T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX47"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BB",
      "display": "Purine analogues",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Purine analogues"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Purinanaloger"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01B",
            "display": "Antimetabolites"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB",
            "display": "L01BB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG11",
      "display": "Anifrolumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anifrolumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anifrolumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA51",
            "display": "Anifrolumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG11",
            "display": "L04AG11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC16",
      "display": "Guselkumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Guselkumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Guselkumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC16",
            "display": "L04AC16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-09-28T00:00:00Z",
            "display": "2017-09-28T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA51",
      "display": "Anifrolumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anifrolumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anifrolumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA51",
            "display": "L04AA51"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA51"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XD05",
      "display": "Temoporfin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Temoporfin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Temoporfin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XD",
            "display": "Sensitizers used in photodynamic/radiation therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XD05",
            "display": "L01XD05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-04-13T00:00:00Z",
            "display": "2004-04-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XD05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC07",
      "display": "Tocilizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tocilizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tocilizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC07",
            "display": "L04AC07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-03-23T00:00:00Z",
            "display": "2009-03-23T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG01",
      "display": "Aminogluthetimide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Aminogluthetimide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aminoglutetimid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG01",
            "display": "L02BG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD",
      "display": "Taxanes",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Taxanes"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Taksaner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD",
            "display": "L01CD"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX04",
      "display": "Vandetanib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vandetanib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vandetanib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE12",
            "display": "Vandetanib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX04",
            "display": "L01EX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BA01",
      "display": "Methotrexate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Methotrexate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Metotreksat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BA",
            "display": "Folic acid analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BA01",
            "display": "L01BA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC10",
      "display": "Ofatumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC10",
            "display": "L01XC10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE53",
      "display": "Larotrectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Larotrectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Larotrektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE53",
            "display": "L01XE53"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE53"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DB10",
      "display": "Amrubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Amrubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Amrubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB10",
            "display": "L01DB10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA31",
      "display": "Teriflunomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Teriflunomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Teriflunomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA31",
            "display": "L04AA31"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-10-01T00:00:00Z",
            "display": "2013-10-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA31"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CB01",
      "display": "Etoposide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Etoposide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etoposid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CB",
            "display": "Podophyllotoxin derivatives"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CB01",
            "display": "L01CB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BA",
      "display": "Anti-estrogens",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anti-estrogens"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antiøstrogener"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02B",
            "display": "Hormone antagonists and related agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BA",
            "display": "L02BA"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BA"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EG01",
      "display": "Temsirolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Temsirolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Temsirolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EG",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE09",
            "display": "Temsirolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EG01",
            "display": "L01EG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA41",
      "display": "Imlifidase",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Imlifidase"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Imlifidase"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA41",
            "display": "L04AA41"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-04-11T00:00:00Z",
            "display": "2019-04-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA41"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AB05",
      "display": "Certolizumab pegol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Certolizumab pegol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Certolizumab pegol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB05",
            "display": "L04AB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE28",
      "display": "Ceritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ceritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ceritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE28",
            "display": "L01XE28"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-07-15T00:00:00Z",
            "display": "2014-07-15T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE28"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE18",
      "display": "Ruxolitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ruxolitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ruksolitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE18",
            "display": "L01XE18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2012-01-01T00:00:00Z",
            "display": "2012-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01BA04",
      "display": "Pemetrexed",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pemetrexed"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pemetreksed"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BA",
            "display": "Folic acid analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BA04",
            "display": "L01BA04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2004-10-18T00:00:00Z",
            "display": "2004-10-18T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BA04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX55",
      "display": "Rucaparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rucaparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rukaparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX55",
            "display": "L01XX55"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-01-11T00:00:00Z",
            "display": "2017-01-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX55"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CA06",
      "display": "Vintafolide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vintafolide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vintafolid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CA",
            "display": "Vinca alkaloids and analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CA06",
            "display": "L01CA06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-12-10T00:00:00Z",
            "display": "2013-12-10T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CA06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CE",
      "display": "Topoisomerase 1 inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Topoisomerase 1 inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Topoisomerase 1 hemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01C",
            "display": "Plant alkaloids and other natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CE",
            "display": "L01CE"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CE"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG09",
      "display": "Emapalumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Emapalumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Emapalumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA39",
            "display": "Emapalumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG09",
            "display": "L04AG09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FG01",
      "display": "Bevacizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bevacizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bevacizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FG",
            "display": "VEGF/VEGFR (Vascular endothelial growth factor) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC07",
            "display": "Bevacizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FG01",
            "display": "L01FG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AA03",
      "display": "Ethinylestradiol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ethinylestradiol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Etinyløstradiol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AA",
            "display": "Estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AA03",
            "display": "L02AA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EK01",
      "display": "Axitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Axitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Aksitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EK",
            "display": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE17",
            "display": "Axitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EK01",
            "display": "L01EK01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EK01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC02",
      "display": "Basiliximab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Basiliximab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Basiliksimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA09",
            "display": "Basiliximab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC02",
            "display": "L04AC02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC19",
      "display": "Satralizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Satralizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Satralizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC19",
            "display": "L04AC19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EA06",
      "display": "Asciminib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Asciminib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Askiminib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EA",
            "display": "BCR-ABL tyrosine kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EA06",
            "display": "L01EA06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EA06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EL06",
      "display": "Tirabrutinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tirabrutinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tirabrutinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EL",
            "display": "Bruton's tyrosine kinase (BTK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EL06",
            "display": "L01EL06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-01-01T00:00:00Z",
            "display": "2025-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EL06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EF03",
      "display": "Abemaciclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Abemaciclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Abemaciklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EF",
            "display": "Cyclin-dependent kinases (CDK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE50",
            "display": "Abemaciclib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EF03",
            "display": "L01EF03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EF03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX01",
      "display": "Sunitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sunitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sunitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE04",
            "display": "Sunitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX01",
            "display": "L01EX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED05",
      "display": "Lorlatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lorlatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lorlatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01ED",
            "display": "Anaplastic lymphoma kinase (ALK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE44",
            "display": "Lorlatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED05",
            "display": "L01ED05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XG03",
      "display": "Ixazomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ixazomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Iksazomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XG",
            "display": "Proteasome inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX50",
            "display": "Ixazomib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XG03",
            "display": "L01XG03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XG03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE57",
      "display": "Fedratinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fedratinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fedratinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE57",
            "display": "L01XE57"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2019-12-16T00:00:00Z",
            "display": "2019-12-16T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE57"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01FB01",
      "display": "Inotuzumab ozogamicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Inotuzumab ozogamicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Inotuzumabozogamicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FB",
            "display": "CD22 (Clusters of differentitation 22) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC26",
            "display": "Inotuzumab ozogamicin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FB01",
            "display": "L01FB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB05",
      "display": "Rociletinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rociletinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rosiletinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE37",
            "display": "Rociletinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB05",
            "display": "L01EB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX33",
      "display": "Celecoxib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Celecoxib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Celekoksib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX33",
            "display": "L01XX33"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-11-25T00:00:00Z",
            "display": "2003-11-25T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX33"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE05",
      "display": "Sorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE05",
            "display": "L01XE05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-01-01T00:00:00Z",
            "display": "2007-01-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AA50",
      "display": "Ponesimod",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ponesimod"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ponesimod"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA50",
            "display": "L04AA50"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA50"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XL02",
      "display": "Talimogene laherparepvec",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Talimogene laherparepvec"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talimogenlaherparepvek"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX51",
            "display": "Talimogene laherparepvec"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL02",
            "display": "L01XL02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-09-09T00:00:00Z",
            "display": "2022-09-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FA03",
      "display": "Obinutuzumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Obinutuzumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Obinutuzumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FA",
            "display": "CD20 (Clusters of differentitation 20) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC15",
            "display": "Obinutuzumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FA03",
            "display": "L01FA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FE03",
      "display": "Necitumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Necitumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Necitumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FE",
            "display": "EGFR (Epidermal growth factor receptor) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC22",
            "display": "Necitumumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FE03",
            "display": "L01FE03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FE03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EH",
      "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Human epidermal vekstfaktorreseptor 2 (HER2) tyrosinkinasehemmere"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01E",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EH",
            "display": "L01EH"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-13T00:00:00Z",
            "display": "2020-10-13T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EH"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EJ02",
      "display": "Fedratinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fedratinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fedratinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EJ",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE57",
            "display": "Fedratinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EJ02",
            "display": "L01EJ02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EJ02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX83",
      "display": "Para-toluenesulfonamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Para-toluenesulfonamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Para-toluensulfonamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX83",
            "display": "L01XX83"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX83"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG06",
      "display": "Exemestane",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Exemestane"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Eksemestan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG06",
            "display": "L02BG06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD07",
      "display": "Ranimustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ranimustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ranimustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD07",
            "display": "L01AD07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BB05",
      "display": "Fludarabine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fludarabine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fludarabin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BB",
            "display": "Purine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BB05",
            "display": "L01BB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EN02",
      "display": "Pemigatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pemigatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pemigatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EN",
            "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX20",
            "display": "Pemigatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EN02",
            "display": "L01EN02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EN02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX05",
      "display": "Brentuximab vedotin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brentuximab vedotin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brentuksimabvedotin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC12",
            "display": "Brentuximab vedotin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX05",
            "display": "L01FX05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX09",
      "display": "Mogamulizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mogamulizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mogamulizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC25",
            "display": "Mogamulizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX09",
            "display": "L01FX09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-12-02T00:00:00Z",
            "display": "2021-12-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC29",
      "display": "Bermekimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bermekimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bermekimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC29",
            "display": "L01XC29"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-12-01T00:00:00Z",
            "display": "2017-12-01T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC29"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01CX01",
      "display": "Trabectedin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trabectedin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trabektedin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CX",
            "display": "Other plant alkaloids and natural products"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CX01",
            "display": "L01CX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2007-03-04T00:00:00Z",
            "display": "2007-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX01",
      "display": "Lentinan",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lentinan"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lentinan"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX01",
            "display": "L03AX01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AA10",
      "display": "Lenograstim",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lenograstim"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lenograstim"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AA",
            "display": "Colony stimulating factors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AA10",
            "display": "L03AA10"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AA10"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FD05",
      "display": "Trastuzumab duocarmazine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumab duocarmazine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trastuzumabduokarmazin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FD",
            "display": "HER2 (Human epidermal growth factor receptor 2) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FD05",
            "display": "L01FD05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FD05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF05",
      "display": "Itacitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Itacitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Itakitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AF",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA46",
            "display": "Itacitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF05",
            "display": "L04AF05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB12",
      "display": "Albinterferon alfa-2b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Albinterferon alfa-2b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Albinterferon alfa-2b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB12",
            "display": "L03AB12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA47",
      "display": "Inebilizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Inebilizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Inebilizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA47",
            "display": "L04AA47"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA47"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XL07",
      "display": "Idecabtagene vicleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Idecabtagene vicleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Idekabtagenvikleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL07",
            "display": "L01XL07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AG02",
      "display": "Efalizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Efalizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Efalizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AG",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA21",
            "display": "Efalizumab"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AG02",
            "display": "L04AG02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AG02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX08",
      "display": "Poly ICLC",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Poly ICLC"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Poly ICLC"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX08",
            "display": "L03AX08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FY03",
      "display": "Prolgolimab and nurulimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab and nurulimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Prolgolimab og nurulimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FY",
            "display": "Combinations of monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FY03",
            "display": "L01FY03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FY03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AA07",
      "display": "Trofosfamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Trofosfamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Trofosfamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AA",
            "display": "Nitrogen mustard analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AA07",
            "display": "L01AA07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AA07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA58",
      "display": "Efgartigimod alfa",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Efgartigimod alfa"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Efgartigimod alfa"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA58",
            "display": "L04AA58"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA58"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX50",
      "display": "Ixazomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ixazomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Iksazomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX50",
            "display": "L01XX50"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX50"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01DB03",
      "display": "Epirubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Epirubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Epirubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB03",
            "display": "L01DB03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB08",
      "display": "Interferon beta-1b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon beta-1b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon beta-1b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB08",
            "display": "L03AB08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01CD51",
      "display": "Paclitaxel and encequidar",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Paclitaxel and encequidar"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Paklitaksel og encekidar"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01CD",
            "display": "Taxanes"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01CD51",
            "display": "L01CD51"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-05T00:00:00Z",
            "display": "2022-05-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01CD51"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB01",
      "display": "Flutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Flutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Flutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB01",
            "display": "L02BB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04A",
      "display": "Immunosuppressants",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Immunosuppressants"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Immunsuppressive midler"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04A",
            "display": "L04A"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04A"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX40",
      "display": "Omacetaxine mepesuccinate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Omacetaxine mepesuccinate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Omacetaksinmepesuksinat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX40",
            "display": "L01XX40"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2009-12-14T00:00:00Z",
            "display": "2009-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX40"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BG05",
      "display": "Vorozole",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Vorozole"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Vorozol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BG",
            "display": "Aromatase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BG05",
            "display": "L02BG05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BG05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA52",
      "display": "Ofatumumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ofatumumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA52",
            "display": "L04AA52"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA52"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XX79",
      "display": "Eflornithine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Eflornithine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Eflornitin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX79",
            "display": "L01XX79"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-11-15T00:00:00Z",
            "display": "2023-11-15T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX79"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX84",
      "display": "Pelabresib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pelabresib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pelabresib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX84",
            "display": "L01XX84"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX84"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX81",
      "display": "Nirogacestat",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nirogacestat"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nirogacestat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX81",
            "display": "L01XX81"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2024-11-19T00:00:00Z",
            "display": "2024-11-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX81"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AF",
      "display": "Janus-associated kinase (JAK) inhibitors",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Janus-associated kinase (JAK) inhibitors"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Janus-assosierte kinasehemmere (JAK)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04A",
            "display": "Immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AF",
            "display": "L04AF"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-10-30T00:00:00Z",
            "display": "2023-10-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AF"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD06",
      "display": "Nimustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Nimustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Nimustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD06",
            "display": "L01AD06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XG01",
      "display": "Bortezomib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bortezomib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bortezomib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XG",
            "display": "Proteasome inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX32",
            "display": "Bortezomib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XG01",
            "display": "L01XG01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XG01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AH02",
      "display": "Everolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Everolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AH",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA18",
            "display": "Everolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AH02",
            "display": "L04AH02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AH02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC17",
      "display": "Tildrakizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tildrakizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tildrakizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC17",
            "display": "L04AC17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XB",
      "display": "Methylhydrazines",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Methylhydrazines"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Metylhydraziner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01X",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XB",
            "display": "L01XB"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XB"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB02",
      "display": "Erlotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Erlotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Erlotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE03",
            "display": "Erlotinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB02",
            "display": "L01EB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC09",
      "display": "Floxuridine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Floxuridine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Floksuridin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC09",
            "display": "L01BC09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AD03",
      "display": "Voclosporin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Voclosporin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Voklosporin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AD",
            "display": "Calcineurin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AD03",
            "display": "L04AD03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2011-01-01T00:00:00Z",
            "display": "2011-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AD03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE46",
      "display": "Encorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Encorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enkorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE46",
            "display": "L01XE46"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE46"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AC21",
      "display": "Bimekizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Bimekizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Bimekizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC21",
            "display": "L04AC21"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-03-04T00:00:00Z",
            "display": "2021-03-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC21"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EC03",
      "display": "Encorafenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Encorafenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enkorafenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EC",
            "display": "B-Raf serine-threonine kinase (BRAF) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE46",
            "display": "Encorafenib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EC03",
            "display": "L01EC03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EC03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XK52",
      "display": "Niraparib and abiraterone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib and abiraterone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Niraparib og abirateron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK52",
            "display": "L01XK52"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-08-21T00:00:00Z",
            "display": "2023-08-21T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK52"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA55",
      "display": "Sutimlimab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sutimlimab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sutimlimab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA55",
            "display": "L04AA55"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2024-01-19T00:00:00Z",
            "display": "2024-01-19T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA55"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01EX16",
      "display": "Erdafitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Erdafitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Erdafitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX16",
            "display": "L01EX16"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX16"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XK03",
      "display": "Rucaparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Rucaparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Rukaparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX55",
            "display": "Rucaparib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK03",
            "display": "L01XK03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XC26",
      "display": "Inotuzumab ozogamicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Inotuzumab ozogamicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Inotuzumabozogamicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XC",
            "display": "Monoclonal antibodies"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XC26",
            "display": "L01XC26"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2016-02-09T00:00:00Z",
            "display": "2016-02-09T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2022-01-31T00:00:00Z",
            "display": "2022-01-31T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XC26"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AX04",
      "display": "Lenalidomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Lenalidomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lenalidomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX04",
            "display": "L04AX04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2005-10-11T00:00:00Z",
            "display": "2005-10-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02BB04",
      "display": "Enzalutamide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Enzalutamide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Enzalutamid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02BB",
            "display": "Anti-androgens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02BB04",
            "display": "L02BB04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2014-01-02T00:00:00Z",
            "display": "2014-01-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02BB04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XL04",
      "display": "Tisagenlecleucel",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Tisagenlecleucel"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tisagenlekleucel"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XL",
            "display": "Antineoplastic cell and gene therapy"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX71",
            "display": "Tisagenlecleucel"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XL04",
            "display": "L01XL04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-09-09T00:00:00Z",
            "display": "2022-09-09T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XL04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB02",
      "display": "Daunorubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Daunorubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daunorubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB02",
            "display": "L01DB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L02AB02",
      "display": "Medroxyprogesterone",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Medroxyprogesterone"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Medroksyprogesteron"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AB",
            "display": "Progestogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AB02",
            "display": "L02AB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XM03",
      "display": "Olutasidenib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olutasidenib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olutasidenib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XM",
            "display": "Isocitrate dehydrogenase (IDH) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XM03",
            "display": "L01XM03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-01-01T00:00:00Z",
            "display": "2025-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XM03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX17",
      "display": "Capmatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Capmatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Kapmatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX17",
            "display": "L01EX17"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-11-11T00:00:00Z",
            "display": "2020-11-11T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX17"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01DB01",
      "display": "Doxorubicin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Doxorubicin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Doksorubicin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01DB",
            "display": "Anthracyclines and related substances"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01DB01",
            "display": "L01DB01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01DB01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AH01",
      "display": "Sirolimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sirolimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AH",
            "display": "Mammalian target of rapamycin (mTOR) kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA10",
            "display": "Sirolimus"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AH01",
            "display": "L04AH01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2023-12-05T00:00:00Z",
            "display": "2023-12-05T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AH01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AC23",
      "display": "Olokizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olokizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olokizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AC",
            "display": "Interleukin inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AC23",
            "display": "L04AC23"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AC23"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA03",
      "display": "Antilymphocyte immunoglobulin (horse)",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Antilymphocyte immunoglobulin (horse)"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Antilymfocyttimmunglobulin (hest)"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA03",
            "display": "L04AA03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01FX22",
      "display": "Loncastuximab tesirine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Loncastuximab tesirine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Lonkastuksimabtesirin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01FX",
            "display": "Other monoclonal antibodies and antibody drug conjugates"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01FX22",
            "display": "L01FX22"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2022-05-06T00:00:00Z",
            "display": "2022-05-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01FX22"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB15",
      "display": "Ropeginterferon alfa-2b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Ropeginterferon alfa-2b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Ropeginterferon alfa-2b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB15",
            "display": "L03AB15"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2017-12-01T00:00:00Z",
            "display": "2017-12-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB15"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EB07",
      "display": "Dacomitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dacomitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dakomitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EB",
            "display": "Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE47",
            "display": "Dacomitinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EB07",
            "display": "L01EB07"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EB07"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX12",
      "display": "Larotrectinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Larotrectinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Larotrektinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE53",
            "display": "Larotrectinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX12",
            "display": "L01EX12"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-01-04T00:00:00Z",
            "display": "2021-01-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX12"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX02",
      "display": "Asparaginase",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Asparaginase"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Asparaginase"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX02",
            "display": "L01XX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XE33",
      "display": "Palbociclib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Palbociclib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Palbosiklib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE33",
            "display": "L01XE33"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2015-07-06T00:00:00Z",
            "display": "2015-07-06T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE33"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L01XE47",
      "display": "Dacomitinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Dacomitinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dakomitinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE",
            "display": "Protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XE47",
            "display": "L01XE47"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2018-07-11T00:00:00Z",
            "display": "2018-07-11T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2021-03-02T00:00:00Z",
            "display": "2021-03-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XE47"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L02AA01",
      "display": "Diethylstilbestrol",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Diethylstilbestrol"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Dietylstilbøstrol"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L02AA",
            "display": "Estrogens"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L02AA01",
            "display": "L02AA01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L02AA01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX09",
      "display": "Miltefosine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Miltefosine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Miltefosin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX09",
            "display": "L01XX09"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2020-01-06T00:00:00Z",
            "display": "2020-01-06T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX09"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L03AB02",
      "display": "Interferon beta natural",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon beta natural"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Naturlig interferon beta"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB02",
            "display": "L03AB02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EX18",
      "display": "Avapritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Avapritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Avapritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EX",
            "display": "Other protein kinase inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EX18",
            "display": "L01EX18"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-10-04T00:00:00Z",
            "display": "2020-10-04T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EX18"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD05",
      "display": "Fotemustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fotemustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fotemustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD05",
            "display": "L01AD05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA28",
      "display": "Belatacept",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Belatacept"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Belatacept"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA28",
            "display": "L04AA28"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-03-16T00:00:00Z",
            "display": "2010-03-16T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA28"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01BC52",
      "display": "Fluorouracil, combinations",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Fluorouracil, combinations"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Fluorouracil, kombinasjoner"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01BC",
            "display": "Pyrimidine analogues"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01BC52",
            "display": "L01BC52"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01BC52"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AC01",
      "display": "Thiotepa",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Thiotepa"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Tiotepa"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AC",
            "display": "Ethylene imines"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AC01",
            "display": "L01AC01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AC01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XK01",
      "display": "Olaparib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Olaparib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Olaparib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XK",
            "display": "Poly (ADP-ribose) polymerase (PARP) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX46",
            "display": "Olaparib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XK01",
            "display": "L01XK01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XK01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED04",
      "display": "Brigatinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Brigatinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Brigatinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01ED",
            "display": "Anaplastic lymphoma kinase (ALK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE43",
            "display": "Brigatinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED04",
            "display": "L01ED04"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED04"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AX13",
      "display": "Glatiramer acetate",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Glatiramer acetate"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Glatirameracetat"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AX",
            "display": "Other immunostimulants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AX13",
            "display": "L03AX13"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-01-30T00:00:00Z",
            "display": "2003-01-30T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AX13"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XH02",
      "display": "Romidepsin",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Romidepsin"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Romidepsin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XH",
            "display": "Histone deacetylase (HDAC) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX39",
            "display": "Romidepsin"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XH02",
            "display": "L01XH02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XH02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EK02",
      "display": "Cediranib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Cediranib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Cediranib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EK",
            "display": "Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE32",
            "display": "Cediranib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EK02",
            "display": "L01EK02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EK02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX06",
      "display": "Pomalidomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pomalidomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pomalidomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX06",
            "display": "L04AX06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2013-06-28T00:00:00Z",
            "display": "2013-06-28T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L03AB05",
      "display": "Interferon alfa-2b",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-2b"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Interferon alfa-2b"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L03AB",
            "display": "Interferons"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L03AB05",
            "display": "L03AB05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L03AB05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XJ02",
      "display": "Sonidegib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Sonidegib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Sonidegib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XJ",
            "display": "Hedgehog pathway inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX48",
            "display": "Sonidegib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XJ02",
            "display": "L01XJ02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XJ02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01ED01",
      "display": "Crizotinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Crizotinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Krizotinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01ED",
            "display": "Anaplastic lymphoma kinase (ALK) inhibitors"
          }
        },
        {
          "code": "previousVersion",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XE16",
            "display": "Crizotinib"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01ED01",
            "display": "L01ED01"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2020-12-14T00:00:00Z",
            "display": "2020-12-14T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01ED01"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX11",
      "display": "Estramustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Estramustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Estramustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX11",
            "display": "L01XX11"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX11"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EE05",
      "display": "Mirdametinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Mirdametinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Mirdametinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EE",
            "display": "Mitogen-activated protein kinase (MEK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EE05",
            "display": "L01EE05"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2025-01-01T00:00:00Z",
            "display": "2025-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EE05"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01EJ03",
      "display": "Pacritinib",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Pacritinib"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Pakritinib"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01EJ",
            "display": "Janus-associated kinase (JAK) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01EJ03",
            "display": "L01EJ03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2021-11-08T00:00:00Z",
            "display": "2021-11-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01EJ03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01AD03",
      "display": "Semustine",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Semustine"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Semustin"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01AD",
            "display": "Nitrosoureas"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01AD03",
            "display": "L01AD03"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01AD03"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AX02",
      "display": "Thalidomide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Thalidomide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Talidomid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AX",
            "display": "Other immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AX02",
            "display": "L04AX02"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AX02"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA19",
      "display": "Gusperimus",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Gusperimus"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Gusperimus"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA19",
            "display": "L04AA19"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2003-04-25T00:00:00Z",
            "display": "2003-04-25T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA19"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L04AA08",
      "display": "Daclizumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Daclizumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Daklizumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AA",
            "display": "Selective immunosuppressants"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AA08",
            "display": "L04AA08"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2002-02-08T00:00:00Z",
            "display": "2002-02-08T00:00:00Z"
          }
        },
        {
          "code": "toDate",
          "valueCoding": {
            "code": "2008-01-01T00:00:00Z",
            "display": "2008-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AA08"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Slettet",
            "display": "Slettet"
          }
        }
      ]
    },
    {
      "code": "L04AB06",
      "display": "Golimumab",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Golimumab"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Golimumab"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L04AB",
            "display": "Tumor necrosis factor alpha (TNF-alpha) inhibitors"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L04AB06",
            "display": "L04AB06"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2010-01-01T00:00:00Z",
            "display": "2010-01-01T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L04AB06"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    },
    {
      "code": "L01XX35",
      "display": "Anagrelide",
      "designation": [
        {
          "language": "en",
          "use": {
            "code": "term-name"
          },
          "value": "Anagrelide"
        },
        {
          "language": "no",
          "use": {
            "code": "term-name"
          },
          "value": "Anagrelid"
        }
      ],
      "property": [
        {
          "code": "parentATC",
          "valueCoding": {
            "system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/849bc27b-a66d-49ad-9389-d8f19d63b480",
            "code": "L01XX",
            "display": "Other antineoplastic agents"
          }
        },
        {
          "code": "ATCCode",
          "valueCoding": {
            "code": "L01XX35",
            "display": "L01XX35"
          }
        },
        {
          "code": "fromDate",
          "valueCoding": {
            "code": "2006-01-02T00:00:00Z",
            "display": "2006-01-02T00:00:00Z"
          }
        },
        {
          "code": "internalCode",
          "valueCoding": {
            "code": "L01XX35"
          }
        },
        {
          "code": "internalTermStatus",
          "valueCoding": {
            "code": "Godkjent WHO",
            "display": "Godkjent WHO"
          }
        }
      ]
    }
  ]
}

name : Anatomical Therapeutic Chemical classification system - Human - Antineoplastic and immunomodulating agents Examples

{

}

<name value="Anatomical Therapeutic Chemical classification system - Human - Antineoplastic and immunomodulating agents Examples" />